Page last updated: 2024-08-22

galactosamine and Disease Models, Animal

galactosamine has been researched along with Disease Models, Animal in 400 studies

Research

Studies (400)

Timeframe	Studies, this research(%)	All Research%
pre-1990	64 (16.00)	18.7374
1990's	57 (14.25)	18.2507
2000's	95 (23.75)	29.6817
2010's	153 (38.25)	24.3611
2020's	31 (7.75)	2.80

Authors

Authors	Studies
Baluchnejadmojarad, T; Mohamadi-Zarch, SM; Nazari-Serenjeh, M; Nourabadi, D; Ramazi, S; Roghani, M	1
Huang, K; Kong, L; Liu, K; Meng, Q; Sun, H; Wang, C; Wang, L; Wang, S; Wang, X; Wu, J	1
Cho, SB; Choi, YJ; Han, J; Hong, SG; Kang, D; Kang, SS; Kim, DR; Kim, EJ; Lee, DK; Nyiramana, MM; Siregar, AS; Woo, MS	1
Hashimoto, Y; Hatta, M; Kaibori, M; Kotsuka, M; Nakatake, R; Nishizawa, M; Okumura, T; Okuyama, T; Sekimoto, M; Yoshida, T	1
Ahmedy, OA; Ibrahim, SM; Salem, HH; Sayed, NH	1
Andreola, F; Berg, T; Davies, N; Engelmann, C; Ferreira-Gonzalez, S; Fidaleo, M; Forbes, SJ; Habtesion, A; Hammerich, L; Hassan, M; Jalan, R; Kerbert, AJ; Novelli, S; Philips, A	1
Bogunia, E; Czekaj, P; Grajoszek, A; Hermyt, M; Kolanko, E; Król, M; Limanówka, Ł; Michalik, M; Pająk, J; Prusek, A; Sikora, B; Skubis-Sikora, A	1
Kang, DD; Park, J; Park, Y	1
Cai, L; Feng, L; Fu, Y; Gao, Y; Jiang, Z; Liu, S; Wang, Y; Xu, X; Zhang, L; Zhou, C	1
Cao, Y; Li, J; Liu, H; Teng, Y; Xia, X; Zhu, B	1
Chen, L; Pan, Y; Wang, H; Yang, J; Yuan, L	1
Huang, J; Li, L; Shao, R; Shen, Y; Tang, L; Yang, Y; Zhang, L; Zhu, M	1
Feng, X; Guang, C; Li, Y; Qiu, F; Zhao, N	1
Choi, I; Doh, KO; Jeong, JH; Kim, BK; Kim, HS; Kim, JO; Lee, DM; Moon, IJ; Nguyen, TT; Park, JB; Park, PH; Pathak, S; Regmi, S; Seo, Y; Sung, JH; Thanh, TP; Yong, CS; Yook, S	1
Xiao, WZ; Zhang, L	1
Liu, Y; Pu, Z; Zhao, S	1
Jiang, K; Tian, L; Zhang, Z	1
Huang, J; Li, L; Luo, Y; Shen, Y; Tang, L; Yang, Y; Zhang, L	1
Chen, X; Kachman, SD; Li, X; Liu, B; Lu, Y; Muthuraj, PG; Natarajan, SK; Pattabiraman, M; Yu, J; Zempleni, J	1
Dai, J; Gong, X; Huang, J; Li, L; Lin, L; Peng, X; Shen, Y; Tang, L; Wan, J; Yang, Y; Zhang, L	1
Chen, J; Hao, J; Qi, T; Zhu, X	1
Deng, H; Gu, ST; Hao, L; Huang, X; Liu, MW; Wang, X	1
Chen, S; Feng, Z; Lao, L; Lin, X; Pang, L; Pang, X; Qiao, Q; Vonglorkham, S; Wang, D; Wei, J	1
Abed, J; Alon-Maimon, T; Bachrach, G; Fainsod-Levi, T; Granot, Z; Isaacson, B; Maalouf, N; Mandelboim, O; Nejman, D; Nissan, A; Parhi, L; Ponath, F; Sandbank, J; Shhadeh, A; Sol, A; Straussman, R; Vogel, J; Yajuk, O; Yehuda-Shnaidman, E	1
Chen, Y; Du, Y; Gao, L; Li, J; Zhang, Q	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Bai, YF; Fan, XY; Sheng, H; Wang, SW; Wang, W; Weng, YY; Xu, ZC; Zhang, F; Zheng, F; Zhu, XT	1
Chen, L; Chen, X; Jiang, H; Li, L; Lv, L; Wang, K; Wang, Q; Yan, R	1
Guo, Y; Kang, T; Lei, T; Li, C; Li, H; Li, J; Song, C; Sun, M; Wang, N; Yan, Y; Yang, J; Zhang, J	1
Bai, H; Ding, Y; Dou, X; Fan, Y; Han, C; Lai, P; Li, Y; Sheng, Q; Zhang, C	1
Fang, H; Jiang, S; Li, Z; Lu, Y; Ma, Q; Shi, C; Wang, Y; Wu, M; Xu, L; Yang, J; Zhang, L	1
Cheng, M; Cheng, Y; Cheng, Z; Cong, S; Fan, L; Hu, Y; Liu, Y; Yu, L; Zhang, B; Zhao, P; Zhao, X; Zhu, L	1
Dong, W; Song, E; Song, Y	1
Avni, D; Harikumar, KB; Sanyal, AJ; Spiegel, S	1
Hu, K; Huang, J; Li, L; Li, S; Lu, H; Shao, R; Shen, Y; Tang, L; Yang, Y; Zhang, L	1
Chen, L; Chen, Y; Gao, L; Huang, S; Lai, Y; Lv, Z; Mo, C; Wang, Y; Xie, S; Zeng, T; Zhou, C	1
Hwang, YH; Jeong, YH; Kim, TI; Ma, JY; Oh, YC	1
Dhahri, D; Eiamboonsert, S; Hattori, K; Heissig, B; Munakata, S; Nakauchi, H; Okada, Y; Onoda, H; Ota, Y; Salama, Y; Shimazu, H; Tashiro, Y; Tsuda, Y	1
Choi, JH; Cingolani, F; Czaja, MJ; Ilyas, G; Ravenelle, F; Tanaka, KE; Zhao, E	1
Finkin, S; Finkin-Groner, E; Weinstock, M; Zeeli, S	1
Kaibori, M; Kon, M; Miki, H; Nakatake, R; Nishizawa, M; Oishi, M; Okumura, T; Tanaka, Y; Tokuhara, K; Ueyama, Y	1
Jiang, DR; Jiang, W; Zhang, X; Zhao, M; Zhou, AL	1
Liu, YM; Lv, J; Shen, S; Xing, JY; Yu, ZJ; Zeng, QL; Zhang, YY; Zhang, ZH	1
Gong, ZJ; Jiao, FZ; Wang, LW; Zhang, H; Zhang, HY; Zhang, WB	1
Fu, Y; Guo, C; Shi, M; Wang, Y; Wei, Z; Yang, Z; Zhang, X; Zhao, L	1
Cai, L; Feng, L; Gao, Y; He, GL; Jiang, ZS; Li, Y; Pan, MX; Peng, Q; Weng, J	1
Beauchamp, J; Billon, C; Boulinguiez, A; Burris, TP; Delhaye, S; Dombrowicz, D; Duez, HM; Duhem, C; Eeckhoute, J; Ferri, L; Haas, JT; Lancel, S; Mayeuf-Louchart, A; Pourcet, B; Sebti, Y; Sitaula, S; Staels, B; Thorel, Q; Vanhoutte, J; Zecchin, M	1
Chopade, SS; Dhaneshwar, SS	1
Cheng, Y; Diao, BZ; Lu, BL; Wang, YY; Yu, L; Zhong, LH; Zhu, LY	1
Gao, L; Jiang, W; Li, Q; Liang, F; Lin, C; Wang, W; Wu, L; Xu, L; Zhang, Q; Zhang, Z; Zhao, K; Zhou, M	1
Gao, X; Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Ning, C; Sun, H; Sun, P; Wang, C; Yang, X	1
Chen, Y; Cui, M; He, Q; Hong, D; Li, R; Lin, X; Lou, Y; Lv, P; Xia, Y; Xu, C; Xu, D; Zhang, X	1
Ci, X; Fan, X; Feng, H; Lv, H; Wang, L	1
Gu, Y; Li, XR; Wang, HT; Wang, JB; Wang, W; Wang, Y; Yang, S; Zhang, MX; Zhao, YT	1
Ahmadi, AR; Anders, RA; Cameron, AM; Chicco, M; Creamer, TJ; Dor, FJMF; IJzermans, JNM; Sun, Z; Wesson, RN; Williams, GM	1
Cai, E; Fu, T; Li, H; Li, P; Liu, J; Zhao, Y; Zhu, H	1
Dong, LH; Han, JF; Huang, J; Li, HY; Liu, ZM; Xu, GM; Zan, T; Zhang, HN	1
Dai, W; Liu, P; Lu, H; Lu, X; Wang, D; Wang, J; Wang, W; Wang, Z	1
Chen, Z; Li, A; Liu, Y; Lou, G; Qi, J; Ye, D; Zhang, T; Zheng, M	1
Chen, J; Du, Y; Fu, W; Liu, A; Pei, F; Qiao, J; Shen, Y	1
Jiang, Y; Li, Y; Wang, N	1
Hata, T; Hori, T; Nguyen, JH; Rehman, F	1
Cao, J; Chang, CH; Chen, PD; Huang, YJ; Lee, CY; Lee, HS; Wu, YM	1
Chen, EQ; Luo, C; Tang, H; Tao, YC; Wang, ML; Wu, DB	1
Gao, Y; Hao, S; Kong, X; Li, C; Su, F; Sun, Y; Wang, H; Wang, L; Zhang, Z	1
Gong, ZJ; Han, XQ; Li, X; Wang, LK; Wang, LW	1
Bernardini, R; Caprioli, F; Colantoni, A; Cupi, ML; Franzè, E; Gambacurta, A; Macdonald, TT; Maggioni, M; Mattei, M; Monteleone, G; Monteleone, I; Pallone, F; Ranalli, M; Rizzo, A; Ronchetti, G; Sarra, M	1
Devaki, T; Sheriff, SA	1
Gong, X; Jiang, R; Wan, JY; Wang, CD; Yin, XR; Zhang, L	1
Dong, F; Feng, B; Gao, Y; Liu, F; Wei, L; Wu, S	1
Egashira, Y; Furuta, S; Hashimoto, K; Itabashi, M; Kiyono, T; Mochizuki, S; Nagata, M; Nakamura, Y; Ono, S; Park, EY; Sakata, Y; Sanada, H; Sato, K; Shimmura, Y; Suzuki, Y	1
Ichinose, F; Lefer, D; Marutani, E; Shirozu, K; Tokuda, K; Wang, R	1
Guo, J; Li, LJ; Qiu, YQ; Xu, LQ; Zhou, YX	1
Baraldi, M; Borella, P; Caselgrandi, E; Zeneroli, ML	1
Sheik Abdulazeez, S; Thiruvengadam, D	1
Chen, L; Hu, JH; Pang, F; Tong, JJ; Xin, SJ; Xu, ZH; Yang, HZ; Zhang, HY	1
El-Shazly, AM; Hamdan, DI; Mahmoud, MF; Wink, M	1
Enjoji, M; Kato, M; Kotoh, K; Masaki, Y; Miyazaki, M; Nakamuta, M; Takayanagi, R; Tanaka, K; Tanaka, M	1
He, YW; Huang, SF; Liu, W; Wu, F	1
Fan, X; Huang, J; Shen, H; Wang, H; Zhang, B; Zhang, P; Zhong, B; Zhou, R	1
Boscá, L; Calés, C; González-Rodríguez, Á; Martín-Sanz, P; Mojena, M; Montenegro, Y; Pardo, V; Pimentel-Santillana, M; Rico, D; Través, PG; Valverde, AM	1
Farooq, A; Ghani, A; Gorelick, F; Hoque, R; Mehal, WZ	1
Chen, HL; Cheng, SM; Cheng, YJ; Lee, SD; Shyu, WC; Teng, YH	1
Chen, H; Chen, LN; He, Y; Ji, WJ; Li, HY; Liu, JB; Liu, X; Wang, B; Yang, XF	1
Gou, C; Gu, T; Li, X; Qiu, J; Wen, T; Yang, H	1
Ha, FU; Han, T; Liang, N; Nie, XH; Wang, SH; Xiang, HL; Zhu, ZY	1
Farghali, H; Kemelo, MK; Kutinová Canová, N; Wojnarová, L	1
Gong, ZJ; Han, XQ; Li, X; Wang, LK; Wang, LW; Yang, F	1
Almadén, Y; Briceño, FJ; Ciria, R; de la Mata, M; Ferrín, G; Herencia, C; Martínez-Romero, R; Muñoz-Castañeda, JR	1
Bai, L; Chen, Y; Duan, Z; Han, Y; Jiao, M; Ren, F; Shi, H; Wang, X; Wei, L; Wen, T; Zhang, J; Zhang, L; Zhang, X; Zhao, C; Zheng, S; Zhou, L	1
Li, X; Mao, JY; Wang, HY; Xu, YQ; Zhang, H; Zhu, D	1
Chen, H; Gao, Y; Gong, X; Huang, Y; Yang, F; Zhong, J; Zhou, B	1
Chen, D; Chen, Y; Duan, Z; Piao, Z; Ren, F; Wang, X; Wen, T; Yang, B; Yin, J; Zhang, J; Zhang, X; Zheng, S	1
Liang, L; Shi, G; Wu, Y	1
Dong, P; Li, W; Lu, M; Ni, S; Xu, L; Yang, N; Zhang, S	1
Dhawan, A; Filippi, C; Heaton, ND; Hughes, RD; Jitraruch, S; Lehec, SC; Longhi, MS; Mitry, RR; Philippeos, C; Soong, D	1
Elßner, C; Hövelmeyer, N; Jäger, D; Kautz, N; Koehler, BC; Longerich, T; Scherr, AL; Schulze-Bergkamen, H; Urbanik, T; Waisman, A; Welte, S; Wolpert, L	1
Duan, Z; Jiao, M; Ren, F; Zhao, C; Zhou, L	1
Cheng, Y; Gao, Y; Jian, GD; Pan, MX; Zhang, Z; Zhao, YC	1
Brytan, M; Dyrla, P; Kozłowski, W; Patera, J; Saracyn, M; Wańkowicz, Z; Wojtuń, S; Ząbkowski, T; Zdanowski, R	1
Chen, SL; Dong, JZ; Lu, MQ; Ni, SL; Shi, KQ; Wang, LP; Yang, NB; Zhang, SN; Zhu, JH	1
Bai, L; Chen, EQ; Gong, DY; Tang, H	1
Cheng, N; Cheng, X; Huang, J; Lei, W; Li, X; Liu, B; Liu, J; Zhang, L	1
Chen, WL; Jin, LX; Lin, W; Pan, CW; Pan, ZZ; Zheng, Y; Zhou, GY; Zhuge, L	1
Liang, DY; Liu, LM; Tu, WJ; Ye, CG; Yu, FP; Zhao, L; Zhu, T	1
Chen, HL; Chen, YH; Chien, CS; Ho, CM; Ho, SL; Ho, YT; Hu, RH; Lee, PH	1
Ahmad, A; Ahmad, SR; Al-Jenoobi, FI; Al-Mohizea, AM; Alkharfy, KM; Ganaie, MA; Mohsin, K; Raish, M	1
Chen, J; Dong, S; Li, Y; Liu, H; Wang, Y; Xie, J; Zhang, H; Zhang, Y; Zhao, S	1
Brytan, M; Dyrla, P; Gil, J; Kade, G; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Zdanowski, R	1
Cho, HI; Choi, HS; Choi, JW; Hong, JM; Hwan Kwak, J; Kook Lee, S; Lee, DU; Lee, SM	1
Ai, Q; Ao, JE; Duan, R; Ge, P; Gong, X; Lin, L; Zhang, L	1
Hou, J; Jiang, R; Li, J; Sun, B; Wang, X; Xie, Y; Xu, D; Yan, S; Zhang, C	1
Gao, WS; Li, LP; Liu, JY; Wang, HT; Wang, JB; Wang, W; Yan, YC; Zhang, MX; Zhao, YT	1
Abe, K; Inakuma, T; Ishijima, T; Nakai, Y; Suganuma, H; Ushida, Y; Yajima, N; Yoshida, K	1
Ding, CD; Dong, XM; Li, H; Li, WF; Liang, WC; Liao, WQ; Liu, R; Lu, LT; Lu, XC; Luo, GB; Qi, YL; Wang, L; Xu, T	1
Chang, A; Chen, Y; Chuang, TH; Gao, R; Liu, C; Liu, Y; Luo, Y; Shen, W; Sun, P; Xiang, R; Yang, S; Zhou, W	1
Cao, W; Shen, C; Su, M; Wang, W; Wang, Y; Zhao, C; Zhao, X	1
Jaeschke, H; Maes, M; Vinken, M	1
Červinková, Z; Kučera, O; Lotková, H; Sobotka, O	1
Lei, YC; Li, W; Luo, P; Yang, LL; Zheng, PF	1
Hayashi, M; Hirokawa, F; Imai, Y; Jin, D; Komeda, K; Li, ZL; Maemura, K; Osumi, W; Otsuki, Y; Takai, S; Tashiro, K; Uchiyama, K	1
Lei, YC; Li, W; Luo, P; Yang, LL	1
Bernstein, N; Bhattacharya, R; Chae, JJ; Coburn, JM; Elisseeff, JH; Jeon, OH; Kim, C; Kim, DH; Shores, L; Yarema, KJ	1
Li, H; Liu, BR; Pei, FH; Wang, XR; Yan, BZ; Yang, BS; Zhang, YF; Zhu, AC	1
Cao, H; Chen, P; Chen, X; Ding, W; Hao, S; Jiang, J; Jiang, L; Jin, L; Li, J; Li, L; Li, M; Shi, D; Sun, S; Wu, T; Xin, J; Zhang, J; Zhang, L; Zhou, N; Zhou, Q	1
Guo, L; Liu, Q; Shao, Q; Tang, Y; Yang, J; Zheng, S	1
Choi, JW; Kim, IH; Kim, YM; Lee, MK; Nam, TJ	1
Hu, XY; Lin, W; Luo, JX; Yang, F; Zhang, Y; Zhong, S	1
Han, Y; Wu, Z; Zhu, J	1
Fu, J; Gao, DD; Huang, WX; Jia, B; Qin, B; Yang, C	1
Huang, JR; Li, LJ; Li, YT; Yan, D; Yu, CB	1
Cho, JY; Kim, D; Yi, YS	1
Ahamad, SR; Ahmad, A; Al-Jenoobi, FI; Al-Mohizea, AM; Alkharfy, KM; Ansari, MA; Mohsin, K; Raish, M	1
Ding, YT; Han, B; Huang, T; Huang, X; Ren, HZ; Sang, JF; Shi, XL	1
Farghali, H; Kgalalelo Kemelo, M; Kutinová Canová, N; Wojnarová, L	1
Chen, L; Ge, K; Lei, YC; Li, W; Lu, CL; Wu, YH; Yang, LL	1
Azevedo, RA; Éboli, LP; Goldenberg, A; Gonzalez, AM; Lanzoni, VP; Netto, AA; Paula, TS	1
Ahn, B; Cho, WJ; Choi, JH; Choi, YP; Han, SB; Hong, JT; Jung, JK; Kim, Y; Lee, H; Park, SH; Yeo, JH; Yun, CY	1
Hu, D; Li, S; Lu, M; Ni, S; Tang, X; Yang, N; Zhang, S	1
Bao, S; Chen, M; Cheng, Q; Huang, C; Li, N; Liu, C; Shi, G; Yu, K; Zhao, Q; Zheng, J; Zhu, M	1
Gu, Z; Ji, T; Liu, T; Xu, F; You, S; Zhang, S; Zhao, J	1
Han, YP; Yan, C; Zhou, L	1
Egashira, Y; Komano, T; Sanada, H	1
Agusti, A; Boix, J; Cauli, O; Felipo, V; Piedrafita, B; Rodrigo, R	1
Kozłowski, W; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Wesołowski, P	2
Han, QY; Kang, W; Lei, Y; Liu, ZW; Lou, S; Zhang, L	1
Chen, X; Ding, WX; Ni, HM; Schuchmann, M; Yin, XM	1
Chen, J; Dong, L; Guo, Z; Hong, H; Ouyang, C; Ouyang, J; Shen, C; Zeng, K; Zhang, C; Zhang, J; Zhao, Y; Zhu, J	1
BalajiRaghavendran, HR; Devaki, T; Sathivel, A	1
Cheng, PY; Peng, YJ; Wang, CC; Wei, HP; Wu, ES; Yen, MH	1
Chen, YP; Cui, YL; Lin, HL; Qiu, LX; Sun, QF; Zheng, MH	1
Beg, AA; Chen, X; Fan, J; Liao, Y; Ni, HM; Shi, YH; Yin, XM	1
Hwang, SJ; Kang, HE; Kim, SC; Kim, SG; Kim, YW; Lee, CH; Lee, MG	1
Farhood, A; Hong, JY; Jaeschke, H; Lebofsky, M	1
Arunsundar, M; Balaji, R; Krishnakumar, E; Ravichandiran, V; Shanmugarajan, TS; Sivaraman, D; Somasundaram, I	1
Hou, X; Sun, R; Tian, Z; Wei, H; Zhou, R	1
Fukui, H; Kawaratani, H; Kitazawa, T; Tsujimoto, T	2
Andres, T; Blei, MD; Cho, MD; Judy, R	1
Abshagen, K; Eipel, C; Kuhla, A; Menger, MD; Siebert, N; Vollmar, B	1
Alvarez, M; Culebras, JM; González-Gallego, J; Tuñón, MJ	1
Chen, Q; Cheng, X; Du, L; Jin, H; Liu, S; Liu, Y; Shang, Y; Wang, X; Wang, Y; Xiao, W; Yang, X	1
Agüero, G; Alvarez, S; Haro, C; Lazarte, S; Zelaya, H	1
Liu, P; Lv, S; Song, HL	1
Guo, JW; Luo, XP; Ning, Q; Xi, D; Yan, WM	1
Inoue, Y; Kubo, T; Kuromiya, A; Okazaki, H; Omodani, T; Sato, F; Shiratake, R	1
Jiang, YZ; Lian, LH; Nan, JX; Wu, YL	1
Ando, K; Sato, A; Shimizu, H; Sugiyama, A; Takeuchi, T	1
Damjanov, I; Wan, YJ; Wang, K	1
Chen, HS; Dong, FT; Feng, B; Gao, Y; Liu, F; Lv, S; Wei, L; Wu, SM	1
Hou, W; Liu, Z; Meng, QH; Piao, ZF; Zhang, HY	1
Cui, W; Li, LX; Liu, P; Lv, S; Song, HL; Wang, W; Zhou, Y	1
Morikawa, T	1
Huang, XF; Li, YM; Liu, QQ; Nie, QH; Wang, AH; Yang, J	1
Aqil, M; Najmi, AK; Pal, SN; Pillai, KK; Sayeed, A	1
Fu, JL; Li, GZ; Liu, P; Wang, YR; Wang, ZH	1
Cisney, ED; Fernandez, S; Kissner, TL; Ruthel, G; Saikh, KU; Ulrich, RG	1
Ando, K; Arimura, Y; Dang, MH; Haruta, I; Imanishi, K; Kato, H; Kotani, T; Omori-Miyake, M; Ozaki, M; Suzuki, K; Uchiyama, T; Ueshiba, H; Yagi, J; Yamagoe, S	1
Cai, XF; Jin, X; Lee, JJ; Lian, LH; Nan, JX; Wu, YL	1
Lian, LH; Nan, JX; Wan, Y; Wu, YL	1
Cheung, CK; Lam, SP; Lo, CM; Luk, JM; Man, K; Ng, KT; Rose-John, S	1
Cavar, I; Culo, F; Kelava, T	1
Badamtseren, B; Haque, A; Koide, N; Komatsu, T; Morikawa, A; Naiki, Y; Odkhuu, E; Yokochi, T; Yoshida, T	1
Abe, M; Fukuhama, C; Kagawa, K; Kominami, A; Nakamura, M; Nakao, M; Nakaoka, F; Sasakawa, Y; Yamamoto, K	1
Lian, LH; Nan, JX; Song, SZ; Wan, Y; Wu, YL; Zheng, ZW	1
Avlas, O; Ben-Ari, Z; Cheporko, Y; Greif, F; Hochhauser, E; Pappo, O; Ravid, A; Shapiro, R; Sharon, E; Zilbermints, V	1
Cerný, D; Farghali, H; Hořínek, A; Kameníková, L; Kmoníčková, E; Lekić, N; Muchová, L; Váňová, K; Zídek, Z	1
David, CS; Marietta, EV; Patel, R; Rajagopalan, G; Tilahun, AY; Wu, TT	1
Ho, ST; Huang, CC; Kuo, YH; Lin, CC; Lin, CT; Tung, YT; Wu, JH	1
Bernardi, P; Brusilow, WS; Chiara, F; Jambekar, AA; Needleman, R; Nicolosi, L; Palma, E; Petronilli, V; Rasola, A	1
Chu, XH; Ding, YT; Gu, JY; Han, B; Ren, HZ; Shi, XL; Tan, JJ; Xiao, JQ; Zhang, Y	1
Chen, Y; Duan, Z; Guo, Y; Hu, J; Li, J; Qiao, F; Song, H; Sun, S; Tomlinson, S; Wu, Y; Xu, G; Yang, F; Yu, H; Zhao, G; Zhou, X; Zhou, Y	1
Behlke, MA; Cantin, EM; Jung, SJ; Lundberg, P; Rose, SD; Yang, HJ	1
Lau, TY; Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J	1
Baine, AM; Chen, F; Gardner, LB; Hori, T; Nguyen, JH; Uemoto, S	1
Das, J; Ghosh, J; Roy, A; Sil, PC	1
Avlas, O; Bachmetov, L; Ben Ari, Z; Cheporko, Y; Grief, F; Hochhauser, E; Pappo, O; Shainberg, A; Sharon, E; Zemel, R; Zilbermints, V	1
Adaramoye, OA; Farombi, EO; Odunewu, AO	1
Du, Z; Duan, C; Lin, Q; Qiu, L; Wang, C; Wang, H; Wang, J; Wang, Y; Wen, X	1
Cheng, YW; Hsu, CA; Huang, CC; Lin, KJ; Shyur, LF; Yang, SS	1
Kawashima, K; Komatsu, K; Nakagawa, D; Tanaka, H	1
Carson, DJ; Kulkarni, RM; Kutcher, LW; Leonis, MA; Stuart, WD; Waltz, SE	1
Conde-Vancells, J; Falcon-Perez, JM	1
Hokari, A; Ishii, O; Ishikawa, T; Kawahara, K; Kurihara, T; Maruyama, I; Matsuda, T; Matsumoto, N; Okuse, C; Tajiri, H; Takahashi, H; Zeniya, M	1
Irie, K; Kiyonari, H; Kizaka-Kondoh, S; Lopez-Ramos, DA; Masutani, H; Matsuo, Y; Nakamura, H; Oka, S; Okawa, K; Okuyama, H; Son, A; Tian, H; Yodoi, J	1
Rajamurugan, R; Ramamurthy, CH; Reddy, GP; Selvaganabathy, N; Sujatha, V; Suyavaran, A; Thirunavukkarasu, C	1
Balasekar, P; Banu, S; Bhaskar, B	1
Li, F; Liu, Y; Wen, T; Wen, Z	1
Cao, X; Li, J; Liu, T; Liu, Y; Liu, Z; Wang, Y; Wilson, B; Xiao, N	1
Chen, L; Chen, Y; Duan, Z; Han, Y; Ma, Y; Piao, Z; Ren, F; Wen, T; Zhang, H; Zhang, J; Zheng, S; Zhou, L	1
Bai, L; Chen, EQ; Gong, DY; Leng, XH; Liu, C; Tang, H; Wang, LC	1
Adachi, Y; Hozumi, H; Murakami, T; Ohno, N; Tada, R	1
Chen, CW; Fan, Z; Jia, Y; Lu, L; Mao, Y; Peng, YS; Song, Y; Yang, W; Zeng, M; Zhu, HY	1
Agli, A; Bang, R; Heinlein, S; Sass, G; Schümann, J; Tiegs, G	1
Bamberger, DM; Gao, JJ; Morrison, DC; Papasian, CJ; Silverstein, R	1
Bajt, ML; Ho, YS; Jaeschke, H; Vonderfecht, SL	1
Li, G; Wu, L; Zhu, J	1
Bernstein, C; Corbin, I; Minuk, GY; Uhanova, J; Zhang, M	1
Aeed, H; Avinoach, I; Avni, Y; Bruck, R; Hershkoviz, R; Shahmurov, M; Shirin, H; Wardi, J	1
Bradford, MA; Butler, NS; Hunninghake, GW; Monick, MM; Powers, LS; Yarovinsky, TO	1
Kobayashi, N; Kodama, M; Kunieda, T; Kurabayashi, Y; Maruyama, M; Nakaji, S; Okitsu, T; Oshita, M; Shibata, N; Takesue, M; Tanaka, N; Totsugawa, T	1
Aggarwal, S; Amiot, BP; Block, GD; Fulmer, ML; Gerber, D; Khanna, A; Kramer, DJ; Mazariegos, GV; Molmenti, E; Patzer, JF; Scott, VL; Wagner, RA; Yin, WY	1
Albertoni, C; Campo, S; Carminati, P; Fabrizi, C; Ghirardi, O; Lauro, GM; Nucera, E; Piovesan, P; Ruggiero, V	1
Collado, JA; Lozano, JM; Medina, T; Muntané, J	1
Chamuleau, RA; Hoekstra, R; van de Kerkhove, MP; van Gulik, TM	1
Horie, T; Masubuchi, Y	1
Bajt, ML; Jaeschke, H	1
Kozłowski, W; Saracyn, M; Wańikowicz, Z	1
Araho, D; Chou, WH; Igarashi, K; Ikeda, T; Inukai, M; Kambara, T; Miyakoshi, M; Mizutani, K; Murakami, T; Takenaka, A	1
Imagawa, T; Kobayashi, N; Kobayashi, Y; Mori, M; Naruto, T; Sugai, T; Yokota, S	1
Cihan, A; Uçan, BH; Yenidünya, S; Yilmaz, E	1
Adachi, K; Arakawa, T; Fujii, H; Fujiwara, H; Ikarashi, Y; Ikemoto, M; Kaneda, K; Kawakita, N; Kitada, T; Kobayashi, S; Kronenberg, M; Mitchell, K; Nakajima, Y; Nakanishi, K; Seki, S; Taniguchi, M; Tsutsui, H	1
Chen, HX; Li, HW; Peng, CH; Shu, M; Wu, WD; Xiao, WD; Zhang, MJ; Zhou, GW	1
Bostick, MK; Campe, CB; Hanson, JC; Kodali, P; Lee, G; Maher, JJ; Yan, J	1
Asada, K; Fukui, H; Ikenaka, Y; Kitade, M; Kojima, H; Nakamura, M; Namisaki, T; Noguchi, R; Sakurai, S; Uemura, M; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H	1
Cao, HC; Chen, JJ; Chen, Y; Chen, YM; Du, WB; Li, J; Li, LJ; Pan, XP; Zhang, YM	1
Imao, M; Imose, M; Moriwaki, H; Nagaki, M	1
Nguyen, JH; Yamamoto, S	1
Bermudez, J; Boada, J; Calafell, R; Cuesta, E; Perales, JC; Roig, T	1
Gotohda, T; Ipposhi, K; Izumi, K; Kaneda, S; Ohnishi, T; Otsuka, T; Satake, N; Shimada, M; Takiguchi, Y; Tashiro, S; Tokunaga, I	1
Amer, S; Hayasidani, H; Hikosaka, K; Hirota, Y; Kang, CB; Koge, K; Koyama, Y; Motobu, M; Nakamura, K; Sameshima, T; Yamada, M	1
Cervinková, Z; Hézová, R; Kand'ár, R; Kucera, O; Lotková, H; Muzáková, V	1
Kuhlmann, WD; Peschke, P	1
Berthiaume, F; Harada, H; Kitajima, M; Kobayashi, N; Obara, H; Shimazu, M; Shimizu, N; Shinoda, M; Suganuma, K; Takayanagi, A; Tanaka, N; Tilles, AW; Tompkins, RG; Toner, M; Totsugawa, T; Wakabayashi, G; Yarmush, ML	1
Amano, S; Harada, N; Ito, M; Kuwahata, M; Miyamoto, K; Oka, T; Segawa, H; Tatsumi, S; Tomoe, Y	1
Aoyagi, Y; Honda, Y; Ichida, T; Matsuda, Y; Suzuki, K; Takamura, M; Tamura, Y; Yamagiwa, S	1
Manna, P; Sil, PC; Sinha, M	1
Chen, H; Dong, F; Feng, B; Li, Y; Liu, F; Lv, S; Wei, L; Wu, S; Yan, X	1
Cui, W; Liu, P; Wen, Y	1
Chen, YB; Fan, ST; Ho, DW; Lam, DK; Ng, IO; To, J	1
Fujii, K; Ichi, I; Iida, C; Koga, E; Kojo, S; Washino, Y	1
Adawi, D; Ahrné, S; Jeppsson, B; Molin, G; Osman, N	1
Aishima, S; Enjoji, M; Fukui, Y; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Nakamuta, M; Takayanagi, R	1
Arteel, GE; Guo, L; McMullen, MR; Nagy, LE; Pritchard, MT; Roychowdhury, S	1
Arai, H; Igarashi, K; Ikeya, M; Kita, A; Takenaka, A	1
Hijikawa, T; Ishizaki, M; Kaibori, M; Kamiyama, Y; Kwon, AH; Matsui, K; Okumura, T; Ozaki, T; Tanaka, H; Tokuhara, K; Uchida, Y	1
Lu, JW; Wang, H; Wei, W; Xu, DX; Zhang, C; Zhao, L	1
Chen, Y; Duan, ZP; Liu, XH; Lu, J; Song, CZ; Wang, TL; Zhang, J; Zhang, LJ	1
Haimerl, F; Hashemolhosseini, S; Lamoureux, N; Sass, G; Shembade, ND; Tannapfel, A; Tiegs, G	1
Aggarwal, S; Lopez, RC; Patzer, JF	1
Fujimoto, M; Fukui, H; Kawaratani, H; Kitazawa, T; Tsujimoto, T	1
Egashira, Y; Kawano, N; Sanada, H	1
Duan, ZH; Li, XY; Lu, JW; Ning, H; Wang, H; Wei, W; Xu, DX; Yan-Li, J; Zhang, C; Zhang, H; Zhao, L	1
Anezaki, Y; Dohmen, T; Goto, T; Ishii, H; Kataoka, E; Ohnishi, H; Ohshima, S; Sato, W; Segawa, D; Shibuya, T; Takeuchi, S; Yamada, I; Yoneyama, K	1
Chen, XY; Wang, F; Wen, T; Wu, H	1
Almagro, A; Ramírez, I; Sánchez, O; Soley, M; Viladrich, M	1
Adeyemo, O; Hanig, JP; Knapton, A; Miller, TJ; Noory, L; Weaver, J	1
Basile, AS; Mullen, K	1
Inoue, K; Satoh, M; Takano, H	1
Gao, HF; Ren, JD; Xia, PY; Xiao, GX	1
Chen, Z; Lou, YJ; Ma, KF; Qi, LY; Yang, HY; Zhu, DY	1
Kommerell, B; Limberg, B	1
Hepp, D	1
Baraldi, M; Zeneroli, ZL	1
Fowler, JM; Jones, EA; Munson, PJ; Schafer, DF; Thakur, AK; Waggoner, JG	1
Chang, TM; Shi, ZQ	2
Brody, LE; Jacobs, R; Jones, EA; Pappas, SC; Schafer, DF	1
Ferenci, P; Jones, EA; Pappas, SC; Schafer, DF	1
Niu, Z	1
Bianchi, L; Grubinger, C; Oberholzer, M; Thölen, H; Zimmerli, W	1
Gibson, RG; Hirschowitz, BI; Mihas, AA; Mihas, TA	1
Blendis, LM; Falk, JA; Falk, RE; Langer, B; Makowka, L; Nossal, N; Phillips, MJ; Rotstein, LE	2
Cornell, RP	1
Braginskiĭ, DM; Erokhina, LG; Farber, NA; Gubskiĭ, LV; Ketiladze, ES	1
Shinohara, T; Tsuji, T	1
Chang, TM; Lister, C	1
Bucklin, SE; Lake, P; Lögdberg, L; Morrison, DC	1
Dixit, V; Gitnick, G	1
Arilla, E; Barrios, V; Boyano-Adánez, MD	1
Lin, CC; Tsai, CC; Yen, MH	1
Carpenter, A; Cohen, J; Evans, TJ; Martin, R; Moyes, D	1
Brackeen, MF; Connolly, KM; Menius, JA; Sekut, L	1
Bucklin, SE; Fujihara, Y; Leeson, MC; Morrison, DC	1
Amiot, B; Bloomer, JR; Cerra, FB; Hu, MY; Hu, WS; Rollins, MD; Sielaff, TD	1
Tiegs, G	1
Lin, CC; Lin, SC; Lin, YH; Shyuu, SJ	1
Hirota, K; Hishinuma, I; Katayama, K; Miyamoto, K; Nagakawa, J; Sonoda, J; Yamanaka, T; Yamatsu, I	1
Hamada, S; Nakagawa, I; Takahashi, I; Xu, L	1
Jiang, GZ; Kato, Y; Koide, N; Morikawa, A; Sugiyama, T; Takahashi, K; Tamada, Y; Yokochi, T	1
Baker, AJ; Crossey, PA; Holt, RI; Jones, JS; Miell, JP; Preedy, VR; Stone, NM	1
Blaauw, B; de Smet, B; Dijkstra, HM; Klasen, HJ; Manson, WL	1
Kimura, T; Kurosaki, Y; Nakayama, T; Okamoto, M; Wang, Z	1
Koide, N; Sasaki, S; Shinji, T; Tsuji, T	1
Zahner, H	1
Angermüller, S; Bohlinger, I; Gantner, F; Leist, M; Tiegs, G; Wendel, A	1
Bailat, S; Baumgartner, JD; Di Padova, F; Glauser, MP; Heumann, D; Le Roy, D; Rietschel, ET	1
Blumenthal, S; Diaz-Buxo, JA; Gordon, B; Gores, P; Hayes, D	1
Adawi, D; Jeppsson, B; Molin, G	1
Hayashi, T; Ishiguro, I; Kongo, M; Nagata, M; Nishida, K; Ohta, Y; Sasaki, E	1
Nyberg, SL	1
Farhood, A; Fisher, MA; Jaeschke, H; Jones, DA; Lawson, JA; Simmons, CA	1
Burger, R; Dettmer, R; Hallatschek, W; Lamping, N; Pfeil, D; Schröder, NW; Schumann, RR	1
Fukada, M; Kato, Y; Kawai, M; Koide, N; Morikawa, A; Sugiyama, T; Yokochi, T; Yoshida, T	1
Danker, K; Horstkorte, R; Lucka, L; Reutter, W; Sel, S	1
Chakravortty, D; Kato, Y; Koide, N; Morikawa, A; Sugiyama, T; Yokochi, T; Yoshida, T	1
Brouckaert, P; Libert, C; van Molle, W	1
Kalpana, K; Ong, HS; Prema Raj, J; Soo, KC; Tan, SY	1
Handa, SS; Karan, M; Vasisht, K	1
Briand, P; Dhainaut, JF; Fabre, M; Joulin, V; Kahn, A; Martin, S; Mignon, A; Pagès, JC; Rouquet, N	1
Chow, AW; De Boer, ML; Kum, WW; Pang, LT	1
Andersen, SR; Bjune, G; Froholm, LO; Lovik, M; Oftung, F	1
Boone, T; Guo, J; Mak, TW; Martin, L; Senaldi, G; Shaklee, CL; Ulich, TR	1
Hayes, PC; Nelson, LJ; Newsome, PN; Plevris, JN	1
Brouckaert, P; Libert, C; Van Molle, W; Vanden Berghe, J	1
Kim, HP; Kim, SY; Kim, YC; Lee, EJ; Lee, HS	1
Galun, E; Pappo, O; Peters, M; Rose-John, S; Zeira, E	1
Anilkumar, T; Aslam, M; Ben-Hamida, AJ; Courtney, JM; Gaylor, JD; Khorsandi, SE; Pusey, CD; Ryan, CJ	1
De Freitas, LA; De Souza, VL; Pompeu, MM; Rao, VS; Santos, FA; Silva, RM; Teixeira, MJ; Tomé, AR	1
Balis, UJ; Shito, M; Tompkins, RG; Toner, M; Yarmush, ML	1
Filipponi, F; Mosca, F	1
Lagovsky, I; Meshorer, A; Novogrodsky, A; Patya, M; Vanichkin, A	1
Förster, K; Förster, L; Leinweber, B; Platt, D	1
Gochman, N; Sell, S; Stillman, D	1
Higashi, T; Nagashima, H; Watanabe, A	1
Matas, AJ; Najarian, JS; Simmons, RL; Sommer, BG; Sutherland, DE	1
Broillet, A; Perrissoud, D; Ponard, G	1
Gilbertson, E; McDevitt, C; Muir, H	1
Chang, TM; Chirito, E; Lister, C; Reiter, B	1
Berk, PD; Blitzer, BL; Butler, J; Goodman, DG; Gralnick, HR; Jones, EA; Kopin, IJ; Teychenne, PF; Towne, D; Waggoner, JG; Walters, I; Weise, V	1
Gröflin, UB; Thölen, H	1
Kuiken, LB; Ragland, JB; Sabesin, SM	2
Gerok, W; Pausch, J; Wohleb, B	1
Guerrero, MA; Kositzki, H; Köstering, H; Riesenkampff, WG	1
Lapis, K; Szende, B; Tompa, A	1
Decker, K	1
Leinweber, B; Mahrt, R	1
James, GW; Parker, FL; Pickering, RW	2
Bleyl, U; Müller-Berghaus, G; Reuter, C	1
Gross, V; Heinrich, PC; Weiss, E	1
Efimova, LV; Katarzhnova, TV; Liubarev, AE; Medvednik, RS; Obol'nikova, EA; Poznanskaia, AA; Shaposhnikov, VM; Sugrobova, NP	1
Ebersole, JL; Holt, SC; Kesavalu, L; Machen, RL	1
Badger, AM; Esser, KM; Greig, RG; Lee, JC; Olivera, DL	1
Hartung, T; Tiegs, G; Wendel, A	1
Hayashi, M; Kunitomo, M; Yamaguchi, Y; Yamazoe, H	1
Shiota, T; Tominaga, S; Tsuchida, T; Watanabe, A	1
Bratt, G; Buchthal, S; Garwood, M; Hendrich, K; Merkle, H; Uğurbil, K; Weisdorf, S; Wike, J	1
Chang, TM; Kashani, SA	2
Sawamura, T; Shiozaki, Y	1
Kubo, K; Ohishi, E; Yoshitake, I	1
Franks, AK; Kujawa, KI; Yaffe, LJ	1
Hartung, T; Wendel, A	1
Basile, AS; Gammal, SH; Jones, EA; Ostrowski, NL; Skolnick, P	1
Ito, I; Kosugi, I; Muro, H; Shirasawa, H	1
Christoffersen, CA; Johnson, DC; Morrison, DC; Silverstein, R; Turley, BR	1
Hickman, R; Terblanche, J	1
Bogers, WM; Daha, MR; Muizert, Y; Stad, RK; van Es, LA	1
Handa, SS; Sharma, A	1
Bassett, ML; Fenstermacher, JD; Jones, EA; Mullen, KD; Scholz, B	1
Gramminger, K; Henne-Bruns, D; Kremer, B; Krüger, U	1
Badger, AM; Hanna, N; Olivera, D; Talmadge, JE	1
Meza, MA; Mourelle, M	1
Biempica, L; Czaja, MJ; Flanders, KC; Klein, C; Weiner, FR; Zern, MA	1
Berning, A; Kujawa, KI; Odeyale, C; Yaffe, LJ	1
Chamuleau, RA; de Haan, JG; Deutz, NE; van Gool, J	1
Brachtel, D; Richter, E	1
Malchesky, PS; Nose, Y; Okabe, K; Sakamoto, H; Smith, JW; Takaoka, T; Tuthill, RJ; Usami, M	1
Taoka, Y	1
Rajacic, Z; Thölen, H; Zimmerli, W	1
Siblíková, O; Trcka, V	1
Baue, AE; Chaudry, IH; Clemens, MG; Hayashi, H; Ohkawa, M	1
Biou, D; Durand, D; Durand, G; Féger, J; Monnet, D	1
Petzold, H	1
Leber, HW; Leinweber, B; Platt, D	1
Decker, K; Keppler, D	2
Gmaz-Nikulin, E; Stern, P	1
Brunswig, D; Grün, M; Grün, W; Liehr, H; Rasenack, U	1
Brachtel, D; Gallenkamp, H; Richter, E	1
Meyer-Burg, J	1
Habersang, S; Kozlik, V; Leuschner, F; von Schlichtegroll, A	1
Decker, K; Keppler, D; Lesch, R; Reutter, W	1
Bachmann, W; Bauer, C; Lesch, R; Reutter, W	1
Hirner, A; Meyer-Burg, J	1
Bachmann, W; Reutter, W	1

Reviews

14 review(s) available for galactosamine and Disease Models, Animal

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Experimental models of hepatotoxicity related to acute liver failure. Toxicology and applied pharmacology, 2016, Jan-01, Volume: 290 Topics: Acetaminophen; Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Fas Ligand Protein; Galactosamine; Humans; Liver Failure, Acute	2016
In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs. Physiological research, 2016, 12-21, Volume: 65, Issue:Suppl 4 Topics: Animals; Biomedical Research; Disease Models, Animal; Down-Regulation; Drug Discovery; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes	2016
Brain edema in acute liver failure. Insight from experimental studies. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 1990, Volume: 42 Suppl Topics: Animals; Brain Edema; Caprylates; Disease Models, Animal; Dogs; Galactosamine; Hepatectomy; Hepatic Artery; Hyperammonemia; Intracranial Hypertension; Ligation; Liver; Liver Failure; Portacaval Shunt, Surgical; Rabbits; Rats	1990
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World journal of gastroenterology, 2009, Jul-07, Volume: 15, Issue:25 Topics: Acetaminophen; Animals; Carbon Tetrachloride; Disease Models, Animal; Galactosamine; Hepatectomy; Humans; Liver Failure, Acute; Liver Regeneration	2009
[Search for TNF-alpha sensitivity degradation principles from medicinal foods-hepatoprotective amide constituents from Thai natural medicine Piper chaba]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:6 Topics: Alkaloids; Amides; Animals; Benzodioxoles; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; Lipopolysaccharides; Mice; Piper; Piperidines; Polyunsaturated Alkamides; Structure-Activity Relationship; Tumor Necrosis Factor-alpha	2010
Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials, 2004, Volume: 25, Issue:9 Topics: Acetaminophen; Animals; Disease Models, Animal; Dogs; Galactosamine; Guidelines as Topic; Hepatectomy; Liver; Liver Failure; Liver, Artificial; Research Design; Swine; Tissue Engineering	2004
Immunotoxicology of host-response-mediated experimental liver injury. Journal of hepatology, 1994, Volume: 21, Issue:5 Topics: Animals; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Galactosamine; Humans; Infections; Lipopolysaccharides; Liver Diseases; Tumor Necrosis Factor-alpha	1994
Animal models of fulminant hepatic failure: a critical evaluation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:1 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Dogs; Galactosamine; Humans; Liver Failure; Mice; Rabbits; Swine	2000
Mechanism and clinical relevance of elevated levels of circulating asialoglycoproteins. Targeted diagnosis and therapy, 1991, Volume: 4 Topics: Acute Disease; Animals; Asialoglycoproteins; Biomarkers; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Models, Animal; Galactosamine; Hepatitis; Humans; Liver Diseases; Liver Neoplasms, Experimental; Liver Regeneration	1991
Animal models of fulminant hepatic failure. Digestive diseases and sciences, 1991, Volume: 36, Issue:6 Topics: Acetaminophen; Animals; Carbon Tetrachloride Poisoning; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatic Artery; Hepatic Encephalopathy; Liver Diseases; Portacaval Shunt, Surgical	1991
[Animal disease models--injury, death and various changes of liver cells]. Nihon rinsho. Japanese journal of clinical medicine, 1985, Volume: 43, Issue:6 Topics: Animals; Cell Survival; Chemical and Drug Induced Liver Injury; Collagen; Cricetinae; Disease Models, Animal; Ethionine; Fatty Liver; Galactosamine; Guinea Pigs; Liver; Lysosomes; Mice; Mitochondria, Liver; Protein Biosynthesis; Rabbits; Rats	1985
Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Reviews of physiology, biochemistry and pharmacology, 1974, Issue:71 Topics: Animals; Blood Coagulation Factors; Carbohydrates; Carcinoma, Hepatocellular; Cell Survival; Chemical and Drug Induced Liver Injury; Deoxy Sugars; Disease Models, Animal; Galactosamine; Galactose; Glucosamine; Hyperbilirubinemia; Liver Neoplasms; Macromolecular Substances; Protein Biosynthesis; Pyrimidine Nucleotides; RNA; Time Factors; Uracil Nucleotides; Uridine; Uridine Diphosphate Sugars	1974
Galactosamine induced liver injury. Progress in liver diseases, 1972, Volume: 4 Topics: Amino Acids; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Fishes; Galactosamine; Gluconeogenesis; Guinea Pigs; Haplorhini; Humans; Liver; Proteins; Rabbits; Rats; RNA; Uracil Nucleotides; Uridine	1972

Trials

2 trial(s) available for galactosamine and Disease Models, Animal

Article

Year

Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.

Annales medico-psychologiques, 2021, Volume: 179, Issue:2

Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021

Efficacy of MK615 for the treatment of patients with liver disorders.

World journal of gastroenterology, 2012, Aug-21, Volume: 18, Issue:31

Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fatty Liver; Female; Galactosamine; Hepatitis C; Hepatitis, Autoimmune; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Plant Extracts; Prunus; Rats; Rats, Wistar; Treatment Outcome

2012

Other Studies

385 other study(ies) available for galactosamine and Disease Models, Animal

Article	Year
Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice. Iranian journal of medical sciences, 2021, Volume: 46, Issue:5 Topics: Animals; Disease Models, Animal; Galactosamine; Interleukin-1beta; Interleukin-6; Iran; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Protective Factors; Toll-Like Receptor 4; Umbelliferones	2021
Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response. International immunopharmacology, 2021, Volume: 100 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cells, Cultured; Chalcones; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Inflammasomes; Inflammation Mediators; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction	2021
Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals. Marine drugs, 2021, Oct-28, Volume: 19, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Aquatic Organisms; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Ostreidae; Peptides; Pyroptosis; Signal Transduction	2021
Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models. Shock (Augusta, Ga.), 2022, 03-01, Volume: 57, Issue:3 Topics: Animals; Cell Culture Techniques; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatocytes; Inflammation Mediators; Liver Failure, Acute; Male; Nitric Oxide Synthase Type II; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sepsis	2022
Naringenin affords protection against lipopolysaccharide/D-galactosamine-induced acute liver failure: Role of autophagy. Archives of biochemistry and biophysics, 2022, 03-15, Volume: 717 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Autophagy; Beclin-1; Caspase 3; Disease Models, Animal; Flavanones; Galactosamine; Humans; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Microtubule-Associated Proteins; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Superoxide Dismutase-1; Tumor Suppressor Protein p53	2022
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF. Journal of hepatology, 2022, Volume: 77, Issue:5 Topics: Acute-On-Chronic Liver Failure; Animals; Carbon Tetrachloride; Disease Models, Animal; Galactosamine; Granulocyte Colony-Stimulating Factor; Inflammation; Lipopolysaccharides; Mice; Sulfonamides; Toll-Like Receptor 4	2022
Dynamics of Acute Liver Injury in Experimental Models of Hepatotoxicity in the Context of Their Implementation in Preclinical Studies on Stem Cell Therapy. Frontiers in bioscience (Landmark edition), 2022, 08-10, Volume: 27, Issue:8 Topics: Animals; Cell- and Tissue-Based Therapy; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Necrosis; Rats	2022
Therapeutic Potential of Antimicrobial Peptide PN5 against Multidrug-Resistant E. coli and Anti-Inflammatory Activity in a Septic Mouse Model. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antimicrobial Peptides; Bacteria; Cytokines; Disease Models, Animal; Escherichia coli; Galactosamine; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinases; NF-kappa B; Pancreatic Elastase; Peptide Hydrolases; Shock, Septic	2022
Establishment of acute liver failure model in Tibetan miniature pig and verified by dual plasma molecular adsorption system. The International journal of artificial organs, 2023, Volume: 46, Issue:3 Topics: Adsorption; Ammonia; Animals; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Necrosis; Swine; Swine, Miniature; Tibet	2023
Rhopilema esculentum polysaccharides enhance epithelial cell barrier in vitro and alleviate chronic colitis in mice. International journal of biological macromolecules, 2023, Jun-30, Volume: 241 Topics: Animals; Arabinose; Caco-2 Cells; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Galactosamine; Galactose; Glucose; Humans; Inflammation; Mannose; Mice; Mice, Inbred C57BL; Polysaccharides	2023
Identification of key immune-related genes associated with LPS/D-GalN-induced acute liver failure in mice based on transcriptome sequencing. PeerJ, 2023, Volume: 11 Topics: Animals; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Transcriptome	2023
Succinate dehydrogenase inhibitor dimethyl malonate alleviates LPS/d-galactosamine-induced acute hepatic damage in mice. Innate immunity, 2019, Volume: 25, Issue:8 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatocytes; Humans; Inflammation Mediators; Lipopolysaccharides; Liver; Male; Malonates; Mice; Mice, Inbred BALB C; Succinate Dehydrogenase	2019
LC-MS/MS Method for Simultaneous Determination of Linarin and Its Metabolites in Rat Plasma and Liver Tissue Samples: Application to Pharmacokinetic and Liver Tissue Distribution Study After Oral Administration of Linarin. Molecules (Basel, Switzerland), 2019, Sep-13, Volume: 24, Issue:18 Topics: Administration, Oral; Animals; Chemical and Drug Induced Liver Injury; Chromatography, Liquid; Disease Models, Animal; Galactosamine; Glycosides; Liver; Male; Plasma; Rats; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tissue Distribution	2019
Intraportally delivered stem cell spheroids localize in the liver and protect hepatocytes against GalN/LPS-induced fulminant hepatic toxicity. Stem cell research & therapy, 2019, 10-16, Volume: 10, Issue:1 Topics: Animals; Cell Culture Techniques; Cell Survival; Dinoprostone; Disease Models, Animal; Galactosamine; Heme Oxygenase-1; Interleukin-10; Lipopolysaccharides; Liver; Liver Failure, Acute; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Nude; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase	2019
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice. Chinese medical journal, 2019, Oct-20, Volume: 132, Issue:20 Topics: Acute Disease; Animals; Apoptosis; Caspases; Disease Models, Animal; Galactosamine; Hepatitis; Hepatocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Piperidines; Receptors, Adiponectin; Transforming Growth Factor alpha	2019
Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro. Drug design, development and therapy, 2019, Volume: 13 Topics: Animals; Apoptosis; Autophagy; Bone Marrow Cells; Disease Models, Animal; Exosomes; Galactosamine; Hepatocytes; Inflammation; Lipopolysaccharides; Liver Failure, Acute; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats	2019
Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway. International immunopharmacology, 2019, Volume: 77 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Galactosamine; Inflammasomes; Inflammation; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Propofol; Protective Agents; Signal Transduction; Toll-Like Receptor 4	2019
Luzindole attenuates LPS/d-galactosamine-induced acute hepatitis in mice. Innate immunity, 2020, Volume: 26, Issue:4 Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Apoptosis; Disease Models, Animal; Galactosamine; Hepatitis; Humans; Interleukin-6; Lipopolysaccharides; Liver; Melatonin; Mice; Mice, Inbred BALB C; Receptors, Melatonin; Tryptamines; Tumor Necrosis Factor-alpha	2020
Protective Role of Shiitake Mushroom-Derived Exosome-Like Nanoparticles in D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice. Nutrients, 2020, Feb-13, Volume: 12, Issue:2 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Exosomes; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages; Mice; Nanoparticles; NLR Family, Pyrin Domain-Containing 3 Protein; Plant Extracts; Protective Agents; Shiitake Mushrooms	2020
Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125 Topics: Acetophenones; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Biopsy; Caspases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Hepatocytes; Immunohistochemistry; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Oxidative Stress; Phosphorylation; Reactive Oxygen Species	2020
Comparative Proteomic Analyses of the Liver in D-Galactosamine-Sensitized Mice Treated with Different Toll-Like Receptor Agonists. Proteomics, 2020, Volume: 20, Issue:8 Topics: Animals; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice, Inbred C57BL; Proteins; Proteomics; Tandem Mass Spectrometry; Toll-Like Receptors	2020
Sedum sarmentosum Bunge extract ameliorates lipopolysaccharide- and D-galactosamine-induced acute liver injury by attenuating the hedgehog signaling pathway via regulation of miR-124 expression. BMC complementary medicine and therapies, 2020, Mar-17, Volume: 20, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; China; Disease Models, Animal; Galactosamine; Hedgehog Proteins; Lipopolysaccharides; Mice; MicroRNAs; Plant Extracts; Sedum	2020
Asiatic acid ameliorates acute hepatic injury by reducing endoplasmic reticulum stress and triggering hepatocyte autophagy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129 Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Proteins; Cell Cycle Checkpoints; Cell Line; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endoplasmic Reticulum Stress; Galactosamine; Hepatocytes; Humans; Lipopolysaccharides; Liver; Male; Mice, Inbred C57BL; Pentacyclic Triterpenes	2020
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nature communications, 2020, 06-26, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colony Count, Microbial; Disease Models, Animal; Disease Progression; DNA, Bacterial; Female; Fusobacterium nucleatum; Galactosamine; Galactose; Genome, Bacterial; Humans; Immunity; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Metastasis	2020
Efficacy of decoction from Jieduan Niwan formula on rat model of acute-on-chronic liver failure induced by porcine serum. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2020, Volume: 40, Issue:4 Topics: Acute-On-Chronic Liver Failure; Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Drugs, Chinese Herbal; Galactosamine; Humans; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; Rats; Rats, Wistar; Serum; Swine; Tumor Necrosis Factor-alpha	2020
Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/CREB pathway. International immunopharmacology, 2020, Volume: 89, Issue:Pt B Topics: Acetylation; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Enzyme Activation; Galactosamine; HEK293 Cells; Hesperidin; Humans; Liver; Macrophages; Male; Mice; Mice, Inbred BALB C; Protein Processing, Post-Translational; RAW 264.7 Cells; Signal Transduction; Sirtuin 1; Transcription Factor RelA	2020
Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 133 Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dysbiosis; Galactosamine; Gastrointestinal Microbiome; Ileum; Inflammation Mediators; Limosilactobacillus reuteri; Liver; Liver Failure; Male; Metabolome; Peroxisome Proliferator-Activated Receptors; Probiotics; Rats, Sprague-Dawley; Signal Transduction; Transcriptome	2021
Longan (Dimocarpus longan Lour.) Aril ameliorates cognitive impairment in AD mice induced by combination of D-gal/AlCl Journal of ethnopharmacology, 2021, Mar-01, Volume: 267 Topics: Aluminum Chloride; Alzheimer Disease; Animals; Apoptosis; Behavior, Animal; Brain; Cognition; Cognitive Dysfunction; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Galactosamine; Maze Learning; Mice; Mitogen-Activated Protein Kinase Kinases; Nootropic Agents; Oxidative Stress; Phosphorylation; Plant Extracts; ras Proteins; Sapindaceae; Signal Transduction	2021
STAT6 up-regulation amplifies M2 macrophage anti-inflammatory capacity through mesenchymal stem cells. International immunopharmacology, 2021, Volume: 91 Topics: Animals; Cell Communication; Cells, Cultured; Chemical and Drug Induced Liver Injury; Coculture Techniques; Disease Models, Animal; Galactosamine; Hepatocytes; Inflammation Mediators; Liver; Liver Failure, Acute; Macrophages; Male; Mesenchymal Stem Cell Transplantation; Phenotype; Rats, Wistar; Signal Transduction; STAT6 Transcription Factor; Up-Regulation	2021
Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury. International immunopharmacology, 2021, Volume: 91 Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Cell Line; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Galactosamine; Humans; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Male; Mice, Inbred C57BL; Phosphorylation; Signal Transduction; Zinc Finger E-box Binding Homeobox 2	2021
Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance. Scientific reports, 2021, 01-15, Volume: 11, Issue:1 Topics: Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Down-Regulation; Fecal Microbiota Transplantation; Galactosamine; Gastrointestinal Microbiome; Interleukin-10; Interleukin-17; Liver Function Tests; Male; Mice; Mice, Inbred BALB C; Principal Component Analysis; Saccharomyces boulardii; T-Lymphocytes, Regulatory; Th17 Cells; Up-Regulation	2021
Co-administration of lipopolysaccharide and D-galactosamine induces genotoxicity in mouse liver. Scientific reports, 2021, 01-18, Volume: 11, Issue:1 Topics: Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; DNA Damage; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver Failure, Acute; Male; Mice	2021
Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNFα-dependent inflammation and apoptosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:3 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Apoptosis; Disease Models, Animal; Galactosamine; Hepatocytes; Inflammation; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice, Knockout; Phosphotransferases (Alcohol Group Acceptor); Tumor Necrosis Factor-alpha	2021
Stattic alleviates acute hepatic damage induced by LPS/d-galactosamine in mice. Innate immunity, 2021, Volume: 27, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspases; Cyclic S-Oxides; Disease Models, Animal; Galactosamine; Humans; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred BALB C; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha	2021
Lupeol ameliorates LPS/D-GalN induced acute hepatic damage by suppressing inflammation and oxidative stress through TGFβ1-Nrf2 signal pathway. Aging, 2021, 03-11, Volume: 13, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Down-Regulation; Galactosamine; Inflammation; Lipopolysaccharides; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Pentacyclic Triterpenes; Transforming Growth Factor beta1; Up-Regulation; Zebrafish	2021
Forsythia Fruit Prevents Fulminant Hepatitis in Mice and Ameliorates Inflammation in Murine Macrophages. Nutrients, 2021, Aug-23, Volume: 13, Issue:8 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Forsythia; Fruit; Galactosamine; Inflammation Mediators; Lipopolysaccharides; Liver; Macrophages; Male; Massive Hepatic Necrosis; Mice; Mice, Inbred ICR; Oxidative Stress; Plant Extracts; RAW 264.7 Cells	2021
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome. Blood, 2017, 07-06, Volume: 130, Issue:1 Topics: Animals; Disease Models, Animal; Fibrinolysin; Galactosamine; Humans; Macrophage Activation Syndrome; Mice; Mice, Knockout; RAW 264.7 Cells; Toll-Like Receptor 9	2017
Pentamidine blocks hepatotoxic injury in mice. Hepatology (Baltimore, Md.), 2017, Volume: 66, Issue:3 Topics: Animals; Biopsy, Needle; Blotting, Western; Cytokines; Disease Models, Animal; Galactosamine; Immunohistochemistry; In Situ Nick-End Labeling; Lipopolysaccharides; Liver Failure, Acute; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Pentamidine; Random Allocation; Real-Time Polymerase Chain Reaction; Survival Rate	2017
Indoline derivatives mitigate liver damage in a mouse model of acute liver injury. Pharmacological reports : PR, 2017, Volume: 69, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Gene Expression Regulation; I-kappa B Kinase; Indoles; Interleukin-6; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide; RAW 264.7 Cells; Transcription Factors; Tumor Necrosis Factor-alpha	2017
Elental® amino acid component has protective effects on primary cultured hepatocytes and a rat model of acute liver injury. Nutrition research (New York, N.Y.), 2017, Volume: 42 Topics: Acute Disease; Amino Acids; Animals; Cells, Cultured; Disease Models, Animal; Galactosamine; Hepatocytes; Interleukin-1beta; L-Lactate Dehydrogenase; Lipopolysaccharides; Liver; Liver Diseases; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinase; Rats; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha	2017
Inhibitory effect of oxymatrine on hepatocyte apoptosis World journal of gastroenterology, 2017, Jun-07, Volume: 23, Issue:21 Topics: Alanine Transaminase; Alkaloids; Animals; Apoptosis; Aspartate Aminotransferases; Caspase 3; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Galactosamine; Glycogen Synthase Kinase 3 beta; Hepatocytes; Humans; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Microscopy, Electron, Transmission; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinolizines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2017
AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy. Experimental cell research, 2017, 09-15, Volume: 358, Issue:2 Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Cytokines; Disease Models, Animal; Forkhead Box Protein O3; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha	2017
Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97 Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cytokines; Disease Models, Animal; Galactosamine; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Hydroxamic Acids; Inflammation; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4	2018
Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-κB signaling pathway. The Journal of surgical research, 2017, Volume: 220 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Injections, Intraperitoneal; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Protective Agents; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha	2017
Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure. World journal of gastroenterology, 2017, Nov-14, Volume: 23, Issue:42 Topics: Ammonia; Animals; Disease Models, Animal; Galactosamine; Intracranial Pressure; Liver Failure, Acute; Macaca fascicularis; Male; Saphenous Vein	2017
Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice. Gastroenterology, 2018, Volume: 154, Issue:5 Topics: Animals; Caspase 1; Cells, Cultured; Chemical and Drug Induced Liver Injury; Circadian Rhythm; Cytokines; Disease Models, Animal; Galactosamine; Genetic Predisposition to Disease; Inflammasomes; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophage Activation; Macrophages, Peritoneal; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Nuclear Receptor Subfamily 1, Group D, Member 1; Peritonitis; Phenotype; Pyrrolidines; RNA Interference; Severity of Illness Index; Signal Transduction; Thiophenes; Time Factors; Transfection	2018
Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats. World journal of gastroenterology, 2018, Mar-14, Volume: 24, Issue:10 Topics: Animals; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Liberation; Drug Synergism; Galactosamine; Gastric Mucosa; Glucosamine; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Prodrugs; Rats; Rats, Wistar; Severity of Illness Index; Treatment Outcome; Trinitrobenzenesulfonic Acid	2018
Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Microbial pathogenesis, 2018, Volume: 119 Topics: Animals; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Heme Oxygenase-1; Interleukin-6; Lipopolysaccharides; Liver; Liver Function Tests; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Signal Transduction; Triterpenes; Tumor Necrosis Factor-alpha	2018
Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103 Topics: Animals; Antioxidants; Centella; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Heme Oxygenase-1; Lipopolysaccharides; Male; Membrane Proteins; Mice, Inbred Strains; NF-E2-Related Factor 2; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Triterpenes	2018
Protective effects of ginsenoside Rg1 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway. International immunopharmacology, 2018, Volume: 61 Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Galactosamine; Ginsenosides; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Panax; Signal Transduction; Toll-Like Receptor 4	2018
Liver-specific deletion of Eva1a/Tmem166 aggravates acute liver injury by impairing autophagy. Cell death & disease, 2018, 07-10, Volume: 9, Issue:7 Topics: Alanine Transaminase; Animals; Apoptosis Regulatory Proteins; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Genotype; Interleukin-6; Lipopolysaccharides; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Peroxidase; Tumor Necrosis Factor-alpha	2018
Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. International journal of biological macromolecules, 2018, Volume: 119 Topics: Animals; Autophagy; Cytokines; Disease Models, Animal; Female; Galactosamine; Gene Expression Regulation; Inflammation Mediators; Lipopolysaccharides; Liver Failure, Acute; Liver Function Tests; Mice; Mitogen-Activated Protein Kinases; Models, Biological; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Protective Agents; Signal Transduction; Umbelliferones	2018
High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome. World journal of gastroenterology, 2018, Aug-07, Volume: 24, Issue:29 Topics: Animals; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Humans; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Lipopolysaccharides; Liver; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Necrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Specific Pathogen-Free Organisms	2018
Stem Cell Mobilization Is Lifesaving in a Large Animal Preclinical Model of Acute Liver Failure. Annals of surgery, 2018, Volume: 268, Issue:4 Topics: Animals; Benzylamines; Cyclams; Disease Models, Animal; Flow Cytometry; Galactosamine; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Immunohistochemistry; Liver Failure, Acute; Male; Swine	2018
Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Membrane Proteins; Mice, Inbred ICR; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Toll-Like Receptor 4; Xanthones	2018
Betulin inhibits lipopolysaccharide/D-galactosamine-induced acute liver injury in mice through activating PPAR-γ. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106 Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Mice, Inbred BALB C; NF-kappa B; Peroxidase; PPAR gamma; Signal Transduction; Triterpenes; Tumor Necrosis Factor-alpha	2018
Effect of tumor necrosis factor-α on the expression of the ammonia transporter Rhcg in the brain in mice with acute liver failure. Journal of neuroinflammation, 2018, Aug-22, Volume: 15, Issue:1 Topics: Ammonia; Analysis of Variance; Animals; Brain; Cation Transport Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Gene Expression Regulation; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha	2018
AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. EBioMedicine, 2018, Volume: 36 Topics: Animals; Biomarkers; Carrier Proteins; Cell Communication; Disease Models, Animal; Exosomes; Galactosamine; Inflammasomes; Lipopolysaccharides; Liver Failure, Acute; Macrophage Activation; Macrophages; Mesenchymal Stem Cells; Mice; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Thioredoxins	2018
Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice. Microbial pathogenesis, 2018, Volume: 125 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Esculin; Galactosamine; Lipopolysaccharides; Liver; Mice; Protective Agents	2018
Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ. Microbial pathogenesis, 2019, Volume: 128 Topics: Acyclic Monoterpenes; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Galactosamine; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oils, Volatile; Plant Oils; PPAR gamma; Protective Agents; Signal Transduction; Terpenes; Tumor Necrosis Factor-alpha	2019
GABA, γ-Aminobutyric Acid, Protects Against Severe Liver Injury. The Journal of surgical research, 2019, Volume: 236 Topics: Aminosalicylic Acids; Animals; Benzenesulfonates; Disease Models, Animal; Galactosamine; gamma-Aminobutyric Acid; Humans; Injections, Intraperitoneal; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Necrosis; Protective Agents; Signal Transduction; STAT3 Transcription Factor; Treatment Outcome; Tumor Necrosis Factor-alpha	2019
Therapeutic Potential of Plasma Proteins Derived from Umbilical Cord Blood for Acute Liver Failure. Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3 Topics: Adiponectin; Animals; Apoptosis; Blood Proteins; Cell Line; Cell Proliferation; Disease Models, Animal; Fetal Blood; Galactosamine; Hepatocytes; Humans; Liver; Liver Failure, Acute; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred F344; Survival Rate; Treatment Outcome	2019
Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway. Journal of translational medicine, 2019, 05-10, Volume: 17, Issue:1 Topics: Animals; Apolipoprotein A-V; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Galactosamine; Humans; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; NF-kappa B; Signal Transduction; Toll-Like Receptor 4	2019
Protective Effect of Compound Cotinus coggygria Oral Liquid on Mice Acute Liver Injury Induced by D-Galactosamine. Annals of clinical and laboratory science, 2019, Volume: 49, Issue:3 Topics: Acute Disease; Administration, Oral; Alanine Transaminase; Anacardiaceae; Animals; Aspartate Aminotransferases; Disease Models, Animal; Female; Galactosamine; Liver; Male; Mice; Protective Agents	2019
Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure. Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Bacterial Translocation; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Endotoxins; Galactosamine; Inflammation Mediators; Intestinal Mucosa; Liver; Liver Failure, Acute; Male; Permeability; Pyruvates; Rats; Rats, Wistar; Time Factors	2013
IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism. Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:4 Topics: Animals; CD11b Antigen; Cell Proliferation; Chemical and Drug Induced Liver Injury; Coculture Techniques; Concanavalin A; Disease Models, Animal; Down-Regulation; Galactosamine; Hepatitis; Hepatocytes; Humans; Interleukin-17; Interleukins; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Myeloid Cells; Receptors, Chemokine; T-Lymphocytes	2013
Lycopene stabilizes lipoprotein levels during D-galactosamine/lipopolysaccharide induced hepatitis in experimental rats. Asian Pacific journal of tropical biomedicine, 2012, Volume: 2, Issue:12 Topics: Animals; Antioxidants; Carotenoids; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatitis; Lipid Peroxidation; Lipoproteins; Liver; Lycopene; Male; Oxidative Stress; Rats; Rats, Wistar	2012
Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Journal of applied toxicology : JAT, 2014, Volume: 34, Issue:3 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Eleutherococcus; Galactosamine; Glucosides; Lipopolysaccharides; Liver Failure, Acute; Liver Function Tests; Mice; Mice, Inbred BALB C; Phenylpropionates; Protective Agents; Survival Analysis	2014
Metabonomic analysis of liver tissue from BALB/c mice with D-galactosamine/lipopolysaccharide-induced acute hepatic failure. BMC gastroenterology, 2013, Apr-29, Volume: 13 Topics: Amino Acids; Animals; Disease Models, Animal; Fatty Acids; Galactosamine; Gas Chromatography-Mass Spectrometry; Heptoses; Hexoses; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Maltose; Metabolome; Metabolomics; Mice; Mice, Inbred BALB C	2013
Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rats. Journal of agricultural and food chemistry, 2013, Jul-03, Volume: 61, Issue:26 Topics: Animals; Biomarkers; Dipeptides; Disease Models, Animal; Galactosamine; Glutens; Hepatitis; Peptide Fragments; Protective Agents; Protein Hydrolysates; Pyrrolidonecarboxylic Acid; Rats; Triticum	2013
Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure. Antioxidants & redox signaling, 2014, Jan-10, Volume: 20, Issue:2 Topics: Animals; Apoptosis; Caspase 3; Cell Survival; Cystathionine gamma-Lyase; Disease Models, Animal; Galactosamine; Gene Expression Regulation; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages, Peritoneal; Male; Membrane Potential, Mitochondrial; Mice; Models, Biological; NF-E2-Related Factor 2; Oxidation-Reduction; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Quinone Reductases; Sulfides; Thiosulfates; Tumor Necrosis Factor-alpha	2014
Xiao-Chai-Hu Tang in treating model mice with D-galactosamine-induced liver injury. African journal of traditional, complementary, and alternative medicines : AJTCAM, 2012, Volume: 9, Issue:3 Topics: Animals; bcl-2-Associated X Protein; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs, Chinese Herbal; fas Receptor; Galactosamine; Interleukin-6; Liver; Magnoliopsida; Mice; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha	2012
Decrease of brain zinc in experimental hepatic encephalopathy. Brain research, 1983, Jan-03, Volume: 258, Issue:1 Topics: Animals; Brain; Calcium; Copper; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Male; Rats; Rats, Sprague-Dawley; Receptors, GABA; Zinc	1983
Effect of lycopene on oxidative stress induced during D-galactosamine/lipopolysaccharide-sensitized liver injury in rats. Pharmaceutical biology, 2013, Volume: 51, Issue:12 Topics: Animals; Antioxidants; Carotenoids; Chemical and Drug Induced Liver Injury; Comet Assay; Disease Models, Animal; DNA Damage; Galactosamine; Lipid Peroxidation; Lipid Peroxides; Lipopolysaccharides; Liver; Lycopene; Male; Oxidative Stress; Rats; Rats, Wistar	2013
[Orthogonal design based optimization of a mouse model of acute liver failure induced by D-galactosamine and lipopolysaccharide]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:6 Topics: Animals; Apoptosis; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL	2013
Hepatoprotective effect of limonin, a natural limonoid from the seed of Citrus aurantium var. bigaradia, on D-galactosamine-induced liver injury in rats. Naunyn-Schmiedeberg's archives of pharmacology, 2014, Volume: 387, Issue:3 Topics: Administration, Oral; Animals; Citrus; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation; Limonins; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Seeds; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2014
Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats. International journal of molecular medicine, 2014, Volume: 33, Issue:2 Topics: Aldehydes; Animals; Apoptosis; Caspase 3; Disease Models, Animal; Fluconazole; Galactosamine; Hepatocytes; Hypoxia-Inducible Factor 1; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages; Male; Microcirculation; NADPH Oxidase 4; NADPH Oxidases; Nitroimidazoles; Oxidative Stress; Rats; Rats, Wistar; Rhodamines; Up-Regulation	2014
[Protective effect of recombinant TM-N and recombinant soluble RAGE in a mouse model of acute hepatic failure]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:10 Topics: Animals; Disease Models, Animal; Galactosamine; Interleukin-1beta; Liver; Liver Failure, Acute; Mice; Mice, Inbred Strains; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recombinant Proteins; Thrombomodulin; Tumor Necrosis Factor-alpha	2013
Intraperitoneal administration of fetuin-A attenuates D-galactosamine/lipopolysaccharide-induced liver failure in mouse. Digestive diseases and sciences, 2014, Volume: 59, Issue:8 Topics: alpha-2-HS-Glycoprotein; Animals; Apoptosis; Disease Models, Animal; Female; Galactosamine; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Liver Failure; Liver Function Tests; Mice; Mice, Inbred BALB C; Random Allocation; Tumor Necrosis Factor-alpha	2014
Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge. Cell death & disease, 2014, Mar-13, Volume: 5 Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Galactosamine; Gene Expression Profiling; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Suppressor Protein p53	2014
Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology, 2014, Volume: 146, Issue:7 Topics: Animals; Anti-Inflammatory Agents; Arrestins; beta-Arrestin 2; beta-Arrestins; Carrier Proteins; Cell Line; Ceruletide; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Galactosamine; Humans; Immunity, Innate; Inflammasomes; Injections, Intraperitoneal; Interleukin-1beta; Lipopolysaccharides; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreas; Pancreatitis; Receptors, G-Protein-Coupled; RNA Interference; RNA, Small Interfering; Signal Transduction; Sodium Lactate; Toll-Like Receptor 4; Toll-Like Receptors; Transfection	2014
Cordyceps sinensis prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. The American journal of Chinese medicine, 2014, Volume: 42, Issue:2 Topics: Animals; Apoptosis; Aspartate Aminotransferases; Caspases; Cordyceps; Disease Models, Animal; Galactosamine; Gene Expression; Injections, Intraperitoneal; Interleukin-10; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Phytotherapy; Plant Extracts; Superoxide Dismutase; Tumor Necrosis Factor-alpha	2014
Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice. Molecular medicine reports, 2014, Volume: 10, Issue:1 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Galactosamine; Glutathione Peroxidase; Lipopolysaccharides; Liver; Liver Failure, Acute; Malondialdehyde; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinase; Protective Agents; Receptors, Erythropoietin; Recombinant Proteins; RNA, Messenger; Superoxide Dismutase	2014
Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation. Scandinavian journal of gastroenterology, 2014, Volume: 49, Issue:8 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Glycosides; Hepatocytes; Inflammation; Injections, Intraperitoneal; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Treatment Outcome	2014
Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine. European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:8 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Drug Administration Schedule; Galactosamine; Humans; Interleukin-11; Liver; Liver Failure, Acute; Male; Proliferating Cell Nuclear Antigen; Protective Agents; Rats, Sprague-Dawley; Recombinant Proteins; Time Factors	2014
D-galactosamine/lipopolysaccharide-induced hepatotoxicity downregulates sirtuin 1 in rat liver: role of sirtuin 1 modulation in hepatoprotection. Physiological research, 2014, Volume: 63, Issue:5 Topics: Animals; Antioxidants; Carbazoles; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Galactosamine; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes	2014
Sodium butyrate protects against toxin-induced acute liver failure in rats. Hepatobiliary & pancreatic diseases international : HBPD INT, 2014, Volume: 13, Issue:3 Topics: Animals; Biomarkers; Butyric Acid; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Galactosamine; HMGB1 Protein; Inflammation Mediators; Interferon-gamma; Intestinal Mucosa; Intestines; Lipopolysaccharides; Liver; Liver Failure, Acute; Permeability; Protective Agents; Rats, Wistar; Serum Albumin; Serum Albumin, Human; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2014
Cardiotrophin-1 decreases liver apoptosis through calpastatin induction. The Journal of surgical research, 2015, Volume: 193, Issue:1 Topics: Animals; Apoptosis; Calcium-Binding Proteins; Calpain; Caspase 3; Cytokines; Cytoprotection; Disease Models, Animal; DNA Fragmentation; Galactosamine; Hepatocytes; Male; Phosphorylation; Primary Cell Culture; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; Swine	2015
Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway. Cell death & disease, 2014, Aug-28, Volume: 5 Topics: Acute Disease; Adenine; Adult; Animals; Autophagy; Autophagy-Related Protein 7; Cells, Cultured; Chemokines; Cytokines; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Galactosamine; Hepatitis B; Hepatocytes; Humans; Inflammation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Failure; Macrophages; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Middle Aged; Phosphorylation; PPAR alpha; Protective Agents; Pyrimidines; RNA Interference; RNA, Small Interfering; Toll-Like Receptor 4; Transcription Factor RelA	2014
Role of the ¹³C-methacetin breath test in the assessment of acute liver injury in a rat model. World journal of gastroenterology, 2014, Aug-28, Volume: 20, Issue:32 Topics: Acute Disease; Animals; Biomarkers; Biopsy; Breath Tests; Carbon Dioxide; Carbon Isotopes; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fluorescent Dyes; Galactosamine; Indocyanine Green; Liver; Male; Oxyphenonium; Rats, Sprague-Dawley	2014
[Establishment of a rat model of acute liver failure by a modified 90% bloodless hepatectomy and by D-galactosamine and lipopolysaccharide injection]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2014, Volume: 34, Issue:8 Topics: Animals; Disease Models, Animal; Galactosamine; Hepatectomy; Injections, Intraperitoneal; Lipopolysaccharides; Liver Failure, Acute; Rats; Rats, Sprague-Dawley	2014
[Role of endoplasmic reticulum stress in D-GalN/LPS-induced acute liver failure]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:5 Topics: Animals; Apoptosis; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL	2014
[CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2014, Volume: 30, Issue:10 Topics: Acute Disease; ADP-ribosyl Cyclase 1; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Down-Regulation; Galactosamine; Gene Expression; Inflammation Mediators; Injections, Intraperitoneal; Interferon-gamma; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice, Inbred C57BL; Mice, Knockout; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha	2014
Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:10 Topics: Animals; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Drug Administration Schedule; Drug Tolerance; Galactosamine; Inflammation Mediators; Interleukin-1 Receptor-Associated Kinases; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transcription Factor RelA	2014
Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure. PloS one, 2014, Volume: 9, Issue:12 Topics: Alginates; Animals; Cell Survival; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Galactosamine; Glucuronic Acid; Hepatocytes; Hexuronic Acids; Humans; Leukocytes, Mononuclear; Liver Failure, Acute; Liver Regeneration; Male; Microspheres; Rats; Rats, Sprague-Dawley; Transplantation, Heterologous	2014
CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes. World journal of gastroenterology, 2014, Dec-07, Volume: 20, Issue:45 Topics: Animals; Antibodies; Apoptosis; Biomarkers; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cysteine Endopeptidases; Deubiquitinating Enzyme CYLD; Disease Models, Animal; fas Receptor; Galactosamine; Gene Deletion; Hepatocytes; Lipopolysaccharides; Mice, Knockout; NF-kappa B; Receptors, Tumor Necrosis Factor; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha	2014
[The protective role of peroxisome proliferator activated receptors-α and pathomechanism in D-galactosamine/lipopolysaccharide- induced acute liver failure in rats]. Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:9 Topics: Animals; Cytokines; Disease Models, Animal; Galactosamine; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Liver Failure, Acute; Mice; Mice, Inbred C57BL; PPAR alpha; Rats; Tumor Necrosis Factor-alpha	2014
Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure. World journal of gastroenterology, 2014, Dec-14, Volume: 20, Issue:46 Topics: Animals; Biomarkers; Bioreactors; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Equipment Design; Feasibility Studies; Galactosamine; Hepatocytes; Humans; Liver; Liver Failure, Acute; Liver Function Tests; Liver, Artificial; Macaca fascicularis; Male; Time Factors	2014
Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure. World journal of gastroenterology, 2014, Dec-14, Volume: 20, Issue:46 Topics: Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Liver; Liver Failure, Acute; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Rats, Sprague-Dawley; Signal Transduction; Time Factors	2014
LPS pretreatment ameliorates D-galactosamine/lipopolysaccharide-induced acute liver failure in rat. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:11 Topics: Animals; Cytokines; Disease Models, Animal; Endotoxins; Galactosamine; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Specific Pathogen-Free Organisms; Suppressor of Cytokine Signaling Proteins; Tumor Necrosis Factor-alpha; Up-Regulation	2014
Employment of digital gene expression profiling to identify potential pathogenic and therapeutic targets of fulminant hepatic failure. Journal of translational medicine, 2015, Jan-27, Volume: 13 Topics: Animals; Apoptosis; Chemokine CCL3; Chemokine CCL4; Disease Models, Animal; Galactosamine; Gene Expression Profiling; Gene Expression Regulation; Gene Library; High-Throughput Nucleotide Sequencing; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred BALB C; NF-kappa B p50 Subunit; RNA, Messenger; Signal Transduction; Software; Tumor Necrosis Factor-alpha	2015
[Expression of intestinal defensin-5, soluble phospholipase A2 and lysozyme and the relation to bacterial translocation in rat models of acute liver failure]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:12 Topics: Animals; Bacterial Translocation; Defensins; Disease Models, Animal; Galactosamine; Injections, Intraperitoneal; Intestines; Liver Failure, Acute; Male; Muramidase; Phospholipases A2; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger	2014
Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury. International immunopharmacology, 2015, Volume: 26, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Forsythia; Fruit; Galactosamine; Glycosides; Lipid Peroxidation; Lipopolysaccharides; Liver Function Tests; Male; Mice, Inbred BALB C; NF-kappa B; Protective Agents; Tumor Necrosis Factor-alpha	2015
Effects of urotensin-II on cytokines in early acute liver failure in mice. World journal of gastroenterology, 2015, Mar-21, Volume: 21, Issue:11 Topics: Animals; Disease Models, Animal; Galactosamine; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice, Inbred BALB C; Peptide Fragments; Receptors, G-Protein-Coupled; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Urotensins	2015
Transplantation speed offers early hepatocyte engraftment in acute liver injured rats: A translational study with clinical implications. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:5 Topics: Animals; Disease Models, Animal; Galactosamine; Green Fluorescent Proteins; Hepatocytes; Humans; Liver; Liver Failure, Acute; Liver Transplantation; Male; Portal Vein; Rats; Rats, Sprague-Dawley; Time Factors; Translational Research, Biomedical	2015
Hepatoprotective effect of Commiphora myrrha against d-GalN/LPS-induced hepatic injury in a rat model through attenuation of pro inflammatory cytokines and related genes. Pharmaceutical biology, 2015, Volume: 53, Issue:12 Topics: Animals; Chemical and Drug Induced Liver Injury; Commiphora; Cytokines; Disease Models, Animal; Galactosamine; Inflammation Mediators; Lipopolysaccharides; Male; Plant Extracts; Rats; Rats, Wistar	2015
Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure. European journal of nutrition, 2016, Volume: 55, Issue:2 Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Bifidobacterium; Cytokines; Dexamethasone; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Galactosamine; Gastrointestinal Microbiome; JNK Mitogen-Activated Protein Kinases; Lacticaseibacillus casei; Lipopolysaccharides; Liver; Liver Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Probiotics; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 9	2016
D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? Medical science monitor : international medical journal of experimental and clinical research, 2015, May-22, Volume: 21 Topics: Acute Kidney Injury; Alanine Transaminase; Albumins; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Creatinine; Disease Models, Animal; Galactosamine; Hepatocytes; Injections, Intraperitoneal; Liver Failure; Osmolar Concentration; Proteinuria; Rats; Rats, Sprague-Dawley; Specific Gravity; Statistics, Nonparametric; Urea	2015
β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. European journal of pharmacology, 2015, Oct-05, Volume: 764 Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Cytoprotection; Disease Models, Animal; Galactosamine; Inflammation Mediators; Kupffer Cells; Lipopolysaccharides; Liver; Liver Failure; Male; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Polycyclic Sesquiterpenes; Receptor for Advanced Glycation End Products; Sesquiterpenes; Signal Transduction; Time Factors; Toll-Like Receptor 4	2015
Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis. Molecular medicine reports, 2015, Volume: 12, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Disease Models, Animal; Erythropoietin; Galactosamine; Hepatitis; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Matrix Metalloproteinase 3; Metformin; Mice; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thromboplastin; Up-Regulation; Vascular Endothelial Growth Factor A	2015
Aggravated Liver Injury but Attenuated Inflammation in PTPRO-Deficient Mice Following LPS/D-GaIN Induced Fulminant Hepatitis. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 37, Issue:1 Topics: Adaptive Immunity; Animals; Cell Line; Cytokines; Disease Models, Animal; Galactosamine; Hepatitis; Hepatocytes; Immunity, Innate; Inflammation; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Signal Transduction; Spleen; Toll-Like Receptor 4	2015
Development of a rat model of D-galactosamine/lipopolysaccharide induced hepatorenal syndrome. World journal of gastroenterology, 2015, Sep-14, Volume: 21, Issue:34 Topics: Animals; Cytokines; Disease Models, Animal; Galactosamine; Glomerular Filtration Rate; Hepatorenal Syndrome; Kidney; Lipopolysaccharides; Liver; Male; Necrosis; Rats, Sprague-Dawley; Time Factors	2015
Broccoli sprout extract induces detoxification-related gene expression and attenuates acute liver injury. World journal of gastroenterology, 2015, Sep-21, Volume: 21, Issue:35 Topics: Acetaminophen; Animals; Biomarkers; Brassica; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Galactosamine; Gene Expression Profiling; Gene Expression Regulation; Glutathione; Inactivation, Metabolic; Liver; Male; Oligonucleotide Array Sequence Analysis; Phytotherapy; Plant Extracts; Plants, Medicinal; Protective Agents; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Seedlings; Time Factors	2015
Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice. World journal of gastroenterology, 2015, Sep-28, Volume: 21, Issue:36 Topics: Animals; Apoptosis; Caspase 3; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Cytokines; Disease Models, Animal; DNA Damage; Extracellular Signal-Regulated MAP Kinases; Galactosamine; Hepatocytes; Inflammation Mediators; Lipopolysaccharides; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Oxidative Stress; Phosphorylation; RecQ Helicases; Signal Transduction; Time Factors	2015
Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway. The Journal of infectious diseases, 2015, Nov-01, Volume: 212, Issue:9 Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Carrier Proteins; Cell Line; Chemical and Drug Induced Liver Injury; Dependovirus; Disease Models, Animal; Galactosamine; Hepatitis; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; RNA-Binding Proteins; Tumor Necrosis Factor-alpha	2015
[Role of the Notch signaling pathway in development of acute liver failure in a mouse model]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:10 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Galactosamine; HMGB1 Protein; Lipopolysaccharides; Liver Failure, Acute; Mice; RAW 264.7 Cells; Receptors, Notch; RNA, Messenger; Signal Transduction	2015
The effect of D-galactosamine on lean and steatotic rat hepatocytes in primary culture. Physiological research, 2015, Volume: 64, Issue:Suppl 5 Topics: Animals; Apoptosis; Biomarkers; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Necrosis; Non-alcoholic Fatty Liver Disease; Primary Cell Culture; Rats, Wistar; Reactive Oxygen Species	2015
Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells. World journal of gastroenterology, 2015, Dec-14, Volume: 21, Issue:46 Topics: Animals; Chemical and Drug Induced Liver Injury; Cytoplasm; Cytoprotection; Disease Models, Animal; Down-Regulation; Galactosamine; HMGB1 Protein; Kupffer Cells; Liver; Liver Failure, Acute; Male; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Protein Transport; Signal Transduction; Sphingosine; Time Factors	2015
Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice. Journal of pharmacological sciences, 2015, Volume: 129, Issue:4 Topics: Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; HMGB1 Protein; Lipopolysaccharides; Liver; Male; Mice, Inbred C57BL; Neutrophils; Peroxidase; Recombinant Proteins; Solubility; Survival Rate; Thrombomodulin; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2015
Sphingosine kinase 1 dependent protein kinase C-δ activation plays an important role in acute liver failure in mice. World journal of gastroenterology, 2015, Dec-28, Volume: 21, Issue:48 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Biomarkers; Disease Models, Animal; Enzyme Activation; Galactosamine; Inflammation Mediators; Leukocytes, Mononuclear; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase C-delta; Protein Kinase Inhibitors; Signal Transduction; Time Factors	2015
Local delivery of a carbohydrate analog for reducing arthritic inflammation and rebuilding cartilage. Biomaterials, 2016, Volume: 83 Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Cartilage, Articular; Cell Differentiation; Chondrocytes; Chondrogenesis; Disease Models, Animal; Drug Delivery Systems; Extracellular Matrix; Galactosamine; Humans; Inflammation; Male; Osteoarthritis; Rats, Sprague-Dawley; Regeneration	2016
The therapeutic effect of CORM-3 on acute liver failure induced by lipopolysaccharide/D-galactosamine in mice. Hepatobiliary & pancreatic diseases international : HBPD INT, 2016, Volume: 15, Issue:1 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Cytokines; Cytoprotection; Disease Models, Animal; Galactosamine; Inflammation Mediators; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice, Inbred C57BL; Organometallic Compounds; Transcription Factor RelA	2016
Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs. Gut, 2017, Volume: 66, Issue:5 Topics: Animals; Bone Marrow Transplantation; Cytokines; Disease Models, Animal; Galactosamine; Hepatocytes; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Failure, Acute; Male; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Paracrine Communication; Rats; Rats, Sprague-Dawley; Survival Rate; Swine	2017
Effect of bone marrow mesenchymal stem cells transplantation on the serum and liver HMGB1 expression in rats with acute liver failure. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:12 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Blotting, Western; Bone Marrow Transplantation; Disease Models, Animal; Down-Regulation; Galactosamine; HMGB1 Protein; Immunohistochemistry; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mesenchymal Stem Cell Transplantation; Rats, Sprague-Dawley; RNA, Messenger; Time Factors	2015
Pyropia yezoensis glycoprotein regulates antioxidant status and prevents hepatotoxicity in a rat model of D-galactosamine/lipopolysaccharide-induced acute liver failure. Molecular medicine reports, 2016, Volume: 13, Issue:4 Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Cyclooxygenase 2; Disease Models, Animal; Galactosamine; Lipid Peroxidation; Lipopolysaccharides; Liver Failure, Acute; Male; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase Type II; Oxidative Stress; Phosphorylation; Plant Extracts; Protective Agents; Rats; Rhodophyta	2016
Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World journal of gastroenterology, 2016, Feb-28, Volume: 22, Issue:8 Topics: Animals; Biomarkers; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Drugs, Chinese Herbal; Galactosamine; Gene Expression Regulation; HMGB1 Protein; Liver; Liver Failure, Acute; Liver Regeneration; Male; Proliferating Cell Nuclear Antigen; Rats, Wistar; RNA, Messenger; Signal Transduction	2016
[Ephedra protects rats against acute liver failure induced by D-galactosamine and lipopolysaccharide]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016, Volume: 24, Issue:2 Topics: Animals; Disease Models, Animal; Ephedra; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Protective Agents; Rats	2016
Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats. World journal of gastroenterology, 2016, Apr-28, Volume: 22, Issue:16 Topics: Acute-On-Chronic Liver Failure; Adenoviridae; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Disease Models, Animal; Female; Freund's Adjuvant; Galactosamine; Genetic Therapy; Genetic Vectors; HEK293 Cells; Hepatocyte Growth Factor; Humans; Inflammation Mediators; Interleukin-6; Liver; Rats, Sprague-Dawley; Serum Albumin; Serum Albumin, Human; Signal Transduction; Time Factors	2016
Effects of Salmonella infection on hepatic damage following acute liver injury in rats. Hepatobiliary & pancreatic diseases international : HBPD INT, 2016, Volume: 15, Issue:4 Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bacterial Translocation; Bilirubin; Biomarkers; CD3 Complex; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Endotoxins; Galactosamine; Host-Pathogen Interactions; Liver; Male; Peyer's Patches; Rats, Sprague-Dawley; Salmonella enteritidis; Salmonella Infections; T-Lymphocytes; Time Factors	2016
Cerbera manghas methanol extract exerts anti-inflammatory activity by targeting c-Jun N-terminal kinase in the AP-1 pathway. Journal of ethnopharmacology, 2016, Dec-04, Volume: 193 Topics: Animals; Anti-Inflammatory Agents; Apocynaceae; Chemical and Drug Induced Liver Injury; Cytokines; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Galactosamine; HEK293 Cells; Humans; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Kaempferols; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Methanol; Mice; Mice, Inbred C57BL; Peritonitis; Phosphorylation; Phytotherapy; Plant Extracts; Plants, Medicinal; RAW 264.7 Cells; Signal Transduction; Solvents; Time Factors; Transcription Factor AP-1	2016
Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model. BMC complementary and alternative medicine, 2016, Dec-03, Volume: 16, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Lepidium sativum; Lipopolysaccharides; Liver; Liver Failure, Acute; Liver Function Tests; Male; Phytotherapy; Plant Preparations; Protective Agents; Rats, Wistar; Seeds	2016
Intraportal mesenchymal stem cell transplantation prevents acute liver failure through promoting cell proliferation and inhibiting apoptosis. Hepatobiliary & pancreatic diseases international : HBPD INT, 2016, Volume: 15, Issue:6 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Galactosamine; Liver; Liver Failure, Acute; Liver Function Tests; Liver Regeneration; Mesenchymal Stem Cell Transplantation; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Swine; Swine, Miniature; Time Factors	2016
C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. World journal of gastroenterology, 2016, Dec-14, Volume: 22, Issue:46 Topics: Animals; Blotting, Western; Complement C5a; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Galactosamine; HMGB1 Protein; Interleukin-1beta; Interleukin-6; Kaplan-Meier Estimate; Leukocytes, Mononuclear; Lipopolysaccharides; Liver; Liver Failure, Acute; Lysophospholipids; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Phosphotransferases (Alcohol Group Acceptor); Random Allocation; Real-Time Polymerase Chain Reaction; Receptor, Anaphylatoxin C5a; RNA, Messenger; Signal Transduction; Sphingosine; Tumor Necrosis Factor-alpha	2016
Evaluating the best time to intervene acute liver failure in rat models induced by d-galactosamine. Acta cirurgica brasileira, 2016, Volume: 31, Issue:12 Topics: Animals; Apoptosis; Disease Models, Animal; Female; Galactosamine; Injections, Intraperitoneal; Liver; Liver Failure, Acute; Rats; Rats, Wistar; Time Factors	2016
Caffeic Acid Cyclohexylamide Rescues Lethal Inflammation in Septic Mice through Inhibition of IκB Kinase in Innate Immune Process. Scientific reports, 2017, 02-01, Volume: 7 Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Caffeic Acids; Cyclohexylamines; Disease Models, Animal; Galactosamine; Gene Expression Regulation; I-kappa B Kinase; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Docking Simulation; Phosphorylation; RAW 264.7 Cells; Shock, Septic	2017
Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model. Mediators of inflammation, 2017, Volume: 2017 Topics: Acute-On-Chronic Liver Failure; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, Animal; Galactosamine; Interferon-gamma; Interleukin-10; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Rats; Rats, Sprague-Dawley; T-Lymphocytes, Regulatory; Th17 Cells	2017
Interleukin-23 mediates the pathogenesis of LPS/GalN-induced liver injury in mice. International immunopharmacology, 2017, Volume: 46 Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Galactosamine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interleukin-17; Interleukin-23; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Receptors, Interleukin; Survival Analysis; Tumor Necrosis Factor-alpha	2017
Hepatoprotective Effects of Nicotiflorin from Nymphaea candida against Concanavalin A-Induced and D-Galactosamine-Induced Liver Injury in Mice. International journal of molecular sciences, 2017, Mar-08, Volume: 18, Issue:3 Topics: Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Disease Models, Animal; Flavonoids; Galactosamine; Liver Function Tests; Mice; Molecular Structure; Nymphaea; Oxidation-Reduction; Oxidative Stress; Phenols; Plant Extracts; Protective Agents	2017
Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7 Topics: Animals; Carbon Tetrachloride; Caspase 3; Chemical and Drug Induced Liver Injury; Collagen Type IV; Disease Models, Animal; Extracellular Matrix; Galactosamine; Gene Expression Regulation, Enzymologic; Hepatic Stellate Cells; Interleukin-1; Lipopolysaccharides; Liver; Liver Failure, Acute; Longevity; Male; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Necrosis; Rats; Rats, Wistar; RNA, Messenger	2008
L-Gln and L-Ser suppress the D-galactosamine-induced IL-18 expression and hepatitis. Biochemical and biophysical research communications, 2008, Aug-08, Volume: 372, Issue:4 Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Diet; Disease Models, Animal; Galactosamine; Glutamine; Interleukin-18; Male; Rats; Rats, Wistar; RNA, Messenger; Serine; Transaminases	2008
Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain. American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 295, Issue:3 Topics: Ammonia; Animals; Brain; Disease Models, Animal; Disease Progression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Galactosamine; Hepatic Encephalopathy; Hyperammonemia; Infusion Pumps, Implantable; Liver Failure, Acute; Male; Memantine; Microdialysis; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Time Factors	2008
[Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2008, Volume: 24, Issue:142 Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Hepatorenal Syndrome; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley	2008
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2008, Volume: 24, Issue:142 Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Kidney; Liver Failure; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Renal Insufficiency	2008
[Effects of granulocyte colony-stimulating factor on hepatocyte apoptosis in acute liver failure: experiment with rats]. Zhonghua yi xue za zhi, 2008, Apr-08, Volume: 88, Issue:14 Topics: Animals; Apoptosis; Caspase 3; Disease Models, Animal; Female; Flow Cytometry; Galactosamine; Granulocyte Colony-Stimulating Factor; Hepatocytes; Immunohistochemistry; Injections, Intraperitoneal; Liver Failure, Acute; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley	2008
Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. The American journal of pathology, 2008, Volume: 173, Issue:4 Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Caspase 8; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Enzyme Activation; Fas-Associated Death Domain Protein; Galactosamine; Gene Deletion; JNK Mitogen-Activated Protein Kinases; Liver Diseases; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Mutant Proteins; Necrosis; Phosphorylation	2008
A novel fluorescent probe for the detection of nitric oxide in vitro and in vivo. Free radical biology & medicine, 2008, Nov-15, Volume: 45, Issue:10 Topics: Animals; Chemical and Drug Induced Liver Injury; Copper; Disease Models, Animal; Endothelial Cells; Fluorescent Dyes; Galactosamine; Humans; Imidazoles; Lipopolysaccharides; Liver Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organometallic Compounds; Phenols; Time Factors	2008
Stabilization of mitochondrial and microsomal function by polysaccharide of Ulva lactuca on D-Galactosamine induced hepatitis in rats. Chemico-biological interactions, 2009, Jan-27, Volume: 177, Issue:2 Topics: Administration, Oral; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatocytes; Injections, Intraperitoneal; Male; Microsomes, Liver; Mitochondria, Liver; Mitochondrial Membranes; Plant Extracts; Polysaccharides; Rats; Rats, Wistar; Trichloroacetic Acid; Ulva; Urea	2009
Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice. Journal of pharmacological sciences, 2008, Volume: 108, Issue:3 Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Neutrophils; Nitrates; Nitrites; Superoxides; Time Factors; Tumor Necrosis Factor-alpha	2008
Mixed microencapsulation of rat primary hepatocytes and Sertoli cells improves the metabolic function in a D-galactosamine and lipopolysaccharide-induced rat model of acute liver failure. Cytotherapy, 2009, Volume: 11, Issue:3 Topics: Animals; Capsules; Cell Culture Techniques; Cell Line; Disease Models, Animal; Galactosamine; Hepatocytes; Immune Tolerance; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Rats; Recovery of Function; Sertoli Cells	2009
Genetic delineation of the pathways mediated by bid and JNK in tumor necrosis factor-alpha-induced liver injury in adult and embryonic mice. The Journal of biological chemistry, 2009, Feb-13, Volume: 284, Issue:7 Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Embryo, Mammalian; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; MAP Kinase Kinase 4; Mice; Mice, Knockout; Mitochondria, Liver; Mitogens; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2009
Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes. American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Bile; Biotransformation; Carrier Proteins; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Disease Models, Animal; Enzymes; Epoxide Hydrolases; Flavanones; Galactosamine; Glucuronides; Glucuronosyltransferase; Glutathione Transferase; Heme Oxygenase (Decyclizing); Infusions, Intravenous; Isoenzymes; Lipopolysaccharides; Liver; Male; Metabolic Detoxication, Phase II; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Up-Regulation	2009
Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis, and c-Jun NH2-terminal kinase activation. American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:3 Topics: Alanine Transaminase; Aldehydes; Animals; Antifibrinolytic Agents; Apoptosis; Caspases; Chemical and Drug Induced Liver Injury; Diquat; Disease Models, Animal; DNA Fragmentation; Endotoxins; Galactosamine; Glutathione Disulfide; Hepatocytes; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Liver Diseases; Male; Necrosis; Oxidative Stress; Rats; Rats, Inbred F344; Superoxides; Vitamin K 3	2009
Influence of alpha lipoic acid on antioxidant status in D-galactosamine-induced hepatic injury. Toxicology and industrial health, 2008, Volume: 24, Issue:10 Topics: Analysis of Variance; Animals; Antioxidants; Biomarkers; Catalase; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Glutathione; Glutathione Peroxidase; Injections, Intraperitoneal; Lipid Peroxidation; Liver; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thioctic Acid	2008
NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:3 Topics: Animals; Cell Communication; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Galactosamine; Hepatitis; Interferon-gamma; Interleukin-12; Interleukin-18; Killer Cells, Natural; Kupffer Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NK Cell Lectin-Like Receptor Subfamily K; Nuclear Matrix-Associated Proteins; Nucleocytoplasmic Transport Proteins; Poly I-C; Tumor Necrosis Factor-alpha	2009
Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:6 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Galactosamine; Lipid A; Liver Failure, Acute; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2009
Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury. American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Etanercept; Galactosamine; Granzymes; Immunoglobulin G; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Pore Forming Cytotoxic Proteins; Receptors, Tumor Necrosis Factor; RNA, Messenger; Signal Transduction; T-Lymphocytes, Cytotoxic; Time Factors; Transaminases; Tumor Necrosis Factor-alpha	2009
Targeted expression of uncoupling protein 2 to mouse liver increases the susceptibility to lipopolysaccharide/galactosamine-induced acute liver injury. Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:4 Topics: Acute Lung Injury; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Apoptosis; Caspase 3; Cytochromes c; Disease Models, Animal; Female; Galactosamine; Genetic Predisposition to Disease; Hepatocytes; Ion Channels; Lipopolysaccharides; Liver; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Liver; Mitochondrial Proteins; Uncoupling Protein 2	2009
Yogurt: effect on leukocytes and blood coagulation in an acute liver injury model. Journal of medicinal food, 2009, Volume: 12, Issue:4 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Coagulation; Cattle; Cell Death; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fibrinogen; Galactosamine; Goats; Leukocyte Count; Leukocytes; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Neutrophils; Partial Thromboplastin Time; Peroxidase; Probiotics; Prothrombin Time; Yogurt	2009
The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failure. BMC gastroenterology, 2009, Sep-22, Volume: 9 Topics: Animals; Antibodies, Anti-Idiotypic; Colon; Disease Models, Animal; Galactosamine; Intestinal Mucosa; Lipopolysaccharides; Liver Failure, Acute; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Peritonitis; Phosphoproteins; RNA, Messenger; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein	2009
[Establishment of pig acute liver failure model and the role of pig fibrinogen-like protein 2]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:9 Topics: Animals; Disease Models, Animal; Fibrinogen; Galactosamine; Immunohistochemistry; Liver; Liver Failure, Acute; Liver Function Tests; Male; Polymerase Chain Reaction; Random Allocation; RNA, Messenger; Swine	2009
Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury. Bioorganic & medicinal chemistry, 2009, Nov-01, Volume: 17, Issue:21 Topics: Acute Lung Injury; Animals; Cricetinae; Dipeptides; Disease Models, Animal; Galactosamine; Humans; Leukocyte Elastase; Lipopolysaccharides; Mice; Peptides; Proteinase Inhibitory Proteins, Secretory; Solubility	2009
Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:10 Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Caspase 3; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Phenols; Tumor Necrosis Factor-alpha	2009
PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats. The Journal of veterinary medical science, 2010, Volume: 72, Issue:2 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytokines; Disease Models, Animal; Galactosamine; Histocytochemistry; Lactoferrin; Lipopolysaccharides; Liver Failure, Acute; Male; Nitric Oxide; Pilot Projects; Polyethylene Glycols; Rats; Rats, Wistar	2010
The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury. Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:2 Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Pregnane X Receptor; Receptors, Steroid; STAT3 Transcription Factor	2010
A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice. BMC gastroenterology, 2009, Dec-30, Volume: 9 Topics: 3-Hydroxybutyric Acid; Animals; Biomarkers; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Logistic Models; Male; Metabolomics; Mice; Mice, Inbred BALB C; Models, Statistical; Phosphates; Predictive Value of Tests; Prognosis; Ribitol; Urea	2009
[The approaches for making acute-on-chronic liver failure in rat]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2009, Volume: 23, Issue:5 Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Disease Models, Animal; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Male; Random Allocation; Rats; Rats, Sprague-Dawley	2009
Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:8 Topics: Analysis of Variance; Animals; Apoptosis; Blood Chemical Analysis; Blood-Brain Barrier; Blotting, Western; Capillary Permeability; Disease Models, Animal; DNA Primers; Galactosamine; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Liver Failure, Acute; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Occludin; Reverse Transcriptase Polymerase Chain Reaction; Tight Junctions; Tumor Necrosis Factor-alpha	2010
Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats. Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Disease Models, Animal; Galactosamine; Injections, Intravenous; Lipid A; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Rats; Rats, Wistar; Time Factors; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2010
Effects of intestinal intervention on bacterial translocation in a rat model of acute liver failure in vivo. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:11 Topics: Animals; Bacterial Translocation; Bentonite; Cytokines; Disease Models, Animal; Electrophoresis, Agar Gel; Endotoxins; Escherichia coli; Flow Cytometry; Galactosamine; Gastrointestinal Agents; Green Fluorescent Proteins; Intestines; Lactulose; Liver; Liver Failure, Acute; Lymph Nodes; Male; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Silicates; Spleen; Toll-Like Receptor 4	2010
Hepatoprotective and behavioral effects of jigrine in galactosamine-induced hepatopathy in rats. Pharmaceutical biology, 2010, Volume: 48, Issue:7 Topics: Animals; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Galactosamine; Hepatitis; Liver; Male; Maze Learning; Motor Activity; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Silymarin	2010
Decreased IgA+ plasma cells and IgA expression in acute liver necrosis mice. World journal of gastroenterology, 2010, Aug-14, Volume: 16, Issue:30 Topics: Acute Disease; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Galactosamine; Immunity, Mucosal; Immunoglobulin A; Interferon-gamma; Intestinal Mucosa; Intestine, Small; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Necrosis; Plasma Cells; Staining and Labeling	2010
MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice. Innate immunity, 2011, Volume: 17, Issue:5 Topics: Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Enterotoxins; Female; Galactosamine; Gene Expression Regulation; Humans; Inflammation Mediators; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Shock, Septic; Spleen; Staphylococcal Infections	2011
Possible role of LECT2 as an intrinsic regulatory factor in SEA-induced toxicity in d-galactosamine-sensitized mice. Clinical immunology (Orlando, Fla.), 2010, Volume: 137, Issue:3 Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Down-Regulation; Enterotoxins; Female; Flow Cytometry; Galactosamine; Hemorrhage; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Interleukin-6; Liver; Lung; Mice; Mice, Inbred C57BL; Shock, Septic; T-Lymphocytes; Time Factors; Tumor Necrosis Factor-alpha	2010
Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Journal of pharmacological sciences, 2010, Volume: 114, Issue:2 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Caspase 3; Disease Models, Animal; DNA Fragmentation; Down-Regulation; Galactosamine; Glucose; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Nitriles; Plant Extracts; Sedum; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2010
Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models. Chemico-biological interactions, 2010, Dec-05, Volume: 188, Issue:3 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Cytochromes c; Cytoprotection; Disease Models, Animal; Flavanones; Galactosamine; Gene Expression Regulation, Enzymologic; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein	2010
Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:10 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chemotaxis; Coculture Techniques; Cytokine Receptor gp130; Disease Models, Animal; Female; Galactosamine; Gene Expression Regulation; Green Fluorescent Proteins; Hepatocytes; Interleukin-6; Liver Regeneration; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinases; Paracrine Communication; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Signal Transduction; STAT3 Transcription Factor; Time Factors	2010
Influence of small doses of various drug vehicles on acetaminophen-induced liver injury. Canadian journal of physiology and pharmacology, 2010, Volume: 88, Issue:10 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Galactosamine; Lipopolysaccharides; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver	2010
Low susceptibility of NC/Nga mice to the lipopolysaccharide-mediated lethality with D-galactosamine sensitization and the involvement of fewer natural killer T cells. Innate immunity, 2012, Volume: 18, Issue:1 Topics: Animals; Caspase 3; Disease Models, Animal; Disease Susceptibility; Endotoxemia; Galactosamine; Galactose; Galactosylceramides; Immunologic Factors; Interferon-gamma; Lipopolysaccharides; Liver; Lymphocyte Activation; Mice; Mice, Inbred Strains; Natural Killer T-Cells; Nitric Oxide; Nitric Oxide Synthase Type II; Receptors, Antigen, T-Cell, alpha-beta	2012
Effect of globin digest on the liver injury and hepatic gene expression profile in galactosamine-induced liver injury in SD rats. Life sciences, 2011, Apr-11, Volume: 88, Issue:15-16 Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Gene Expression Regulation; Globins; Hepatocytes; Male; Mice; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-met; Rats; Rats, Sprague-Dawley	2011
Betulinic acid prevention of d-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms. The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:4 Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Betulinic Acid; Caspase 3; Catalase; Disease Models, Animal; Galactosamine; Glutathione; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Failure, Acute; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survival Analysis; Triterpenes; Up-Regulation	2011
Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice. Transplantation, 2011, Jul-15, Volume: 92, Issue:1 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Disease Models, Animal; Erythropoietin; Galactosamine; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Kaplan-Meier Estimate; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; NF-kappa B; Recombinant Proteins; Tumor Necrosis Factor-alpha	2011
Hepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: relationship to HO-1/CO antioxidant system. Fitoterapia, 2011, Volume: 82, Issue:5 Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Carbon Monoxide; Chemical and Drug Induced Liver Injury; Curcuma; Curcumin; Disease Models, Animal; Galactosamine; Heme Oxygenase-1; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Signal Transduction	2011
Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome. The American journal of pathology, 2011, Volume: 178, Issue:6 Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Enterotoxins; Galactosamine; Gastrointestinal Tract; HLA-DR3 Antigen; Humans; Imaging, Three-Dimensional; Immunization; Liver; Mice; Mice, Transgenic; Organ Specificity; Permeability; Shock, Septic; Time Factors	2011
Bioactive phytochemicals of leaf essential oils of Cinnamomum osmophloeum prevent lipopolysaccharide/D-galactosamine (LPS/D-GalN)-induced acute hepatitis in mice. Journal of agricultural and food chemistry, 2011, Aug-10, Volume: 59, Issue:15 Topics: Acute Disease; Animals; Cinnamomum; Disease Models, Animal; Galactosamine; Hepatitis; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Oils, Volatile; Plant Leaves; Plant Oils	2011
A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure. Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:8 Topics: Animals; Apoptosis; Cells, Cultured; Cytokines; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Galactosamine; Glutamate-Ammonia Ligase; Inflammation Mediators; Interferon-gamma; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages, Peritoneal; Male; Methionine Sulfoximine; Mice; STAT1 Transcription Factor; Time Factors; Tumor Necrosis Factor-alpha	2011
The influence of membrane molecular weight cutoff on a novel bioartificial liver. Artificial organs, 2012, Volume: 36, Issue:1 Topics: Animals; Bioreactors; Cell Survival; Coculture Techniques; Disease Models, Animal; Dogs; Equipment Design; Galactosamine; Hemodynamics; Hepatocytes; Immunity, Humoral; Liver Failure, Acute; Liver, Artificial; Membranes, Artificial; Mesenchymal Stem Cells; Molecular Weight; Swine	2012
Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure. PloS one, 2011, Volume: 6, Issue:11 Topics: Animals; Complement C3; Complement Membrane Attack Complex; Disease Models, Animal; Drug Combinations; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Anaphylatoxin C5a; Receptors, Complement; Signal Transduction; Survival Rate	2011
Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo. Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-10, Volume: 160, Issue:2 Topics: Animals; CD11b Antigen; Cell Culture Techniques; Cell Line; Chemical and Drug Induced Liver Injury; DEAD-box RNA Helicases; Disease Models, Animal; Down-Regulation; Flow Cytometry; Galactosamine; Injections, Intraperitoneal; Lipopolysaccharides; Liposomes; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Ribonuclease III; RNA, Small Interfering; Sepsis; Transfection; Tumor Necrosis Factor-alpha	2012
Cyclooxygenase inhibitors protect D-galactosamine/lipopolysaccharide induced acute hepatic injury in experimental mice model. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2012, Volume: 50, Issue:3-4 Topics: Alanine Transaminase; Animals; Blotting, Western; Chemical and Drug Induced Liver Injury; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Galactosamine; Immunohistochemistry; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha	2012
Fulminant liver failure models with subsequent encephalopathy in the mouse. Hepatobiliary & pancreatic diseases international : HBPD INT, 2011, Volume: 10, Issue:6 Topics: Animals; Azo Compounds; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Prognosis; Survival Rate; Treatment Outcome; Tumor Necrosis Factor-alpha	2011
Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways. Toxicology and applied pharmacology, 2012, Apr-01, Volume: 260, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Disease Models, Animal; Galactosamine; Gene Expression Regulation; Hepatocytes; Inflammation; Liver Diseases; Male; Mangifera; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Oxidative Stress; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Xanthones	2012
Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2012, Volume: 29, Issue:1-2 Topics: Animals; Apoptosis; Caspase 3; Disease Models, Animal; Down-Regulation; Galactosamine; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Phosphorylation; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2012
Hepatoprotective effect of Curcuma longa L. in D-galactosamine induced liver injury in mice: evidence of antioxidant activity. African journal of medicine and medical sciences, 2010, Volume: 39 Suppl Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Curcuma; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Galactosamine; Glutathione; Injections, Intraperitoneal; Lipid Peroxidation; Liver; Male; Mice; Phytotherapy; Plant Extracts; Tocopherols; Treatment Outcome	2010
Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure. The International journal of artificial organs, 2012, Volume: 35, Issue:6 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Cell Survival; Cells, Cultured; Disease Models, Animal; Galactosamine; Graft Rejection; Graft Survival; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Liver; Liver Failure, Acute; Rats; Rats, Sprague-Dawley; Serum Albumin; Time Factors	2012
Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis. The Journal of nutritional biochemistry, 2013, Volume: 24, Issue:3 Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclooxygenase 2; Disease Models, Animal; Galactosamine; Gene Expression Regulation; Heme Oxygenase-1; Hepatitis; Interleukin-6; Lactones; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 8; NF-kappa B; Phosphorylation; Sesquiterpenes; STAT3 Transcription Factor; Transaminases; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation	2013
[Effect of notoginseng extracts and their components on lipopolysaccharide and galactosamine mixture-induced impaired hepatic function in mice]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:7 Topics: Administration, Ophthalmic; Alanine Transaminase; Animals; Biomarkers; Chemical and Drug Induced Liver Injury, Chronic; Disease Models, Animal; Galactosamine; Interferon-gamma; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Panax notoginseng; Phytotherapy; Plant Extracts; Tumor Necrosis Factor-alpha	2012
Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure. Hepatobiliary & pancreatic diseases international : HBPD INT, 2012, Aug-15, Volume: 11, Issue:4 Topics: Animals; Apoptosis; Blotting, Western; Cells, Cultured; Cytokines; Disease Models, Animal; Disease Progression; Galactosamine; Gene Expression Profiling; Gene Expression Regulation; Immunohistochemistry; Inflammation Mediators; Janus Kinases; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Receptor Protein-Tyrosine Kinases; Signal Transduction; STAT Transcription Factors; Suppressor of Cytokine Signaling Proteins; Time Factors	2012
Isolation of urinary exosomes from animal models to unravel noninvasive disease biomarkers. Methods in molecular biology (Clifton, N.J.), 2012, Volume: 909 Topics: Animals; Biomarkers; Centrifugation, Density Gradient; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Exosomes; Galactosamine; Glycine N-Methyltransferase; Humans; Mice; Mice, Knockout; Proteolysis; Proteome; Rats; Trypsin; Urinalysis	2012
The protective role of the transmembrane thioredoxin-related protein TMX in inflammatory liver injury. Antioxidants & redox signaling, 2013, Apr-10, Volume: 18, Issue:11 Topics: Animals; Apoptosis; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Galactosamine; Gene Expression Regulation; Gene Order; Gene Targeting; Genetic Predisposition to Disease; Hepatitis; Homozygote; Lipopolysaccharides; Liver; Male; Membrane Proteins; Mice; Mice, Knockout; Oxidative Stress; Oxidoreductases; Thioredoxins; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53	2013
Brassica nigra plays a remedy role in hepatic and renal damage. Pharmaceutical biology, 2012, Volume: 50, Issue:12 Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation Mediators; Kidney; Kidney Diseases; Liver; Methanol; Mustard Plant; Oxidative Stress; Plant Extracts; Plant Leaves; Plants, Medicinal; Protective Agents; Rats; Rats, Wistar; Silymarin; Solvents	2012
Hepatoprotective and antioxidant activity of Leucas aspera against D-galactosamine induced liver damage in rats. Pharmaceutical biology, 2012, Volume: 50, Issue:12 Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Female; Galactosamine; Hexobarbital; Hypnotics and Sedatives; Lamiaceae; Lipid Peroxidation; Liver; Mice; Necrosis; Oxidative Stress; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Silymarin; Sleep; Time Factors	2012
Low dose of carbon monoxide intraperitoneal injection provides potent protection against GalN/LPS-induced acute liver injury in mice. Journal of applied toxicology : JAT, 2013, Volume: 33, Issue:12 Topics: Animals; Antioxidants; Apoptosis; Carbon Monoxide; Carboxyhemoglobin; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress	2013
The anti-inflammatory effects of ethyl acetate on Lipopolysaccharide/D-galactosamine challenged mice and Lipopolysaccharide activated RAW264.7 cells. Biochemical and biophysical research communications, 2012, Oct-26, Volume: 427, Issue:3 Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Disease Models, Animal; Galactosamine; Gene Expression; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred Strains; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Protein Transport; Shock, Septic; Tumor Necrosis Factor-alpha	2012
Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis. PloS one, 2012, Volume: 7, Issue:9 Topics: Animals; Apoptosis; Caspase 12; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Activation; Enzyme Inhibitors; Galactosamine; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Maleimides; Mice; Mitogen-Activated Protein Kinase Kinases; Signal Transduction; Toll-Like Receptor 4; Transaminases; Transcription Factor CHOP	2012
Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice. Hepatobiliary & pancreatic diseases international : HBPD INT, 2012, Dec-15, Volume: 11, Issue:6 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Galactosamine; Hepatocyte Nuclear Factor 4; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred BALB C; Plasmids; RNA, Messenger; RNA, Small Interfering; Survival Rate; Transfection; Tumor Necrosis Factor-alpha	2012
Comparative analysis of hepatic CD14 expression between two different endotoxin shock model mice: relation between hepatic injury and CD14 expression. PloS one, 2013, Volume: 8, Issue:1 Topics: Animals; Bile Ducts; Carrageenan; Disease Models, Animal; Female; Galactosamine; Gene Expression; Lipopolysaccharide Receptors; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Shock, Septic; Solubility	2013
[Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:3 Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Calcium Hydroxide; Chemoprevention; Disease Models, Animal; Galactosamine; Liver Cirrhosis; Liver Function Tests; Male; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Transforming Growth Factor beta	2002
Cytokine expression in three mouse models of experimental hepatitis. Cytokine, 2002, Aug-07, Volume: 19, Issue:3 Topics: Animals; Concanavalin A; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Galactosamine; Hepatitis; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-2; Interleukin-4; Interleukin-6; Kinetics; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2002
Anomalous role of tumor necrosis factor alpha in experimental enterococcal infection. Infection and immunity, 2002, Volume: 70, Issue:12 Topics: Animals; Cell Line; Disease Models, Animal; Enterococcus faecalis; Female; Galactosamine; Gram-Positive Bacterial Infections; Humans; Interleukin-6; Macrophages; Mice; Tumor Necrosis Factor-alpha	2002
Reactive oxygen as modulator of TNF and fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice. Antioxidants & redox signaling, 2002, Volume: 4, Issue:5 Topics: Alanine Transaminase; Animals; Apoptosis; Caspase 3; Caspases; Disease Models, Animal; DNA Fragmentation; Enzyme Precursors; fas Receptor; Galactosamine; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hemorrhage; Liver; Mice; Mice, Inbred Strains; Mice, Knockout; Necrosis; Reactive Oxygen Species; Tumor Necrosis Factor-alpha	2002
[Study on hepatic-protective effect of "yinzhihuang" granula]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2001, Volume: 24, Issue:5 Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs, Chinese Herbal; Galactosamine; Liver; Mice; Protective Agents; Rats	2001
Effects of daily, light and moderate-heavy ethanol exposure on extent of hepatic injury and recovery following toxin-induced acute hepatitis in rats. Digestive diseases and sciences, 2003, Volume: 48, Issue:5 Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethanol; Galactosamine; Hepatitis; Liver; Liver Function Tests; Liver Regeneration; Male; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity	2003
Glycine modulates cytokine secretion, inhibits hepatic damage and improves survival in a model of endotoxemia in mice. Liver international : official journal of the International Association for the Study of the Liver, 2003, Volume: 23, Issue:4 Topics: Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Endotoxemia; Escherichia coli; Galactosamine; Glycine; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Liver Diseases; Mice; Mice, Inbred BALB C; Survival Rate	2003
Adenoviral infection decreases mortality from lipopolysaccharide-induced liver failure via induction of TNF-alpha tolerance. Journal of immunology (Baltimore, Md. : 1950), 2003, Sep-01, Volume: 171, Issue:5 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Antigens, CD; Autoantibodies; Cell Line; Disease Models, Animal; fas Receptor; Female; Galactosamine; Humans; Immune Tolerance; Injections, Intraperitoneal; Injections, Intravenous; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Survival Analysis; Tumor Necrosis Factor-alpha; Up-Regulation	2003
Hepatocyte isolation and transplantation in the pig. Cell transplantation, 2003, Volume: 12, Issue:6 Topics: Animals; Cell Separation; Cell Survival; Cell Transplantation; Collagenases; Disease Models, Animal; Endopeptidases; Galactosamine; Hepatocytes; Liver Diseases; Liver Failure, Acute; Liver Transplantation; Male; Perfusion; Survival Rate; Sus scrofa; Transplantation, Heterologous; Treatment Outcome	2003
D-galactosamine based canine acute liver failure model. Hepatobiliary & pancreatic diseases international : HBPD INT, 2002, Volume: 1, Issue:3 Topics: Animals; Disease Models, Animal; Dogs; Galactosamine; Liver; Liver Failure, Acute; Male; Survival Analysis	2002
In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives. Shock (Augusta, Ga.), 2004, Volume: 21, Issue:1 Topics: Administration, Oral; Animals; Blotting, Northern; Cell Line; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enterotoxins; Enzyme Inhibitors; Galactosamine; Humans; Inflammation; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Models, Chemical; Monocytes; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; RNA; RNA Processing, Post-Transcriptional; RNA, Messenger; Shock; Tetrahydronaphthalenes; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2004
Protection against liver injury by PGE1 or anti-TNF-alpha is associated with a reduction of TNF-R1 expression in hepatocytes. Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:11 Topics: Alanine Transaminase; Alprostadil; Animals; Biomarkers; Disease Models, Animal; Galactosamine; Hepatocytes; Immunohistochemistry; Liver; Liver Failure, Acute; Male; Necrosis; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2003
Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:4 Topics: Administration, Oral; Animals; Aryl Hydrocarbon Hydroxylases; Colitis; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Drug Tolerance; Endotoxins; Galactosamine; Immune Tolerance; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Male; Metronidazole; Microsomes, Liver; Polymyxin B; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha	2004
Critical role of CXC chemokines in endotoxemic liver injury in mice. Journal of leukocyte biology, 2004, Volume: 76, Issue:6 Topics: Animals; Antibodies; Apoptosis; Chemokine CXCL1; Chemokine CXCL2; Chemokines; Chemokines, CXC; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Endotoxemia; Endotoxins; Galactosamine; Liver Failure; Mice; Reproducibility of Results; Tumor Necrosis Factor-alpha	2004
[Description of an experimental model of hepatorenal syndrome in Wistar rats]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:98 Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Kidney; Liver Failure; Male; Rats; Rats, Wistar	2004
Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. BioFactors (Oxford, England), 2004, Volume: 21, Issue:1-4 Topics: Ampelopsis; Animals; Disease Models, Animal; Galactosamine; Liver; Liver Function Tests; Male; Phytotherapy; Plant Extracts; Plant Leaves; Plant Stems; Rats; Rats, Wistar	2004
Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury. Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:6 Topics: Animals; Apoptosis; Biological Transport, Active; Blotting, Western; Cell Survival; Cells, Cultured; Cytochromes c; Cytosol; Disease Models, Animal; Female; Galactosamine; Hepatocytes; Immunohistochemistry; In Situ Nick-End Labeling; Lipopolysaccharides; Liver Failure; Mitochondria; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity; Tumor Necrosis Factor-alpha	2004
Medical haemostasis in acute hepatocyte injury and experimental liver trauma. ANZ journal of surgery, 2005, Volume: 75, Issue:4 Topics: Animals; Aprotinin; Blood Coagulation Factors; Blood Loss, Surgical; Blood Volume; Disease Models, Animal; Fibrinolysis; Galactosamine; Guinea Pigs; Hemorrhagic Disorders; Hemostatics; Hepatectomy; Hepatocytes; Liver	2005
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine. Virchows Archiv : an international journal of pathology, 2005, Volume: 446, Issue:6 Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Galactosamine; Galactosylceramides; In Situ Nick-End Labeling; Interferon-gamma; Killer Cells, Natural; Liver; Liver Diseases; Mice; Mice, Knockout; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha	2005
[Establishment of a porcine model of acute hepatic failure by intraportal injection of D-galactosamine and lipopolysaccharide]. Zhonghua yi xue za zhi, 2005, Jun-08, Volume: 85, Issue:21 Topics: Animals; Disease Models, Animal; Female; Galactosamine; Injections, Intravenous; Lipopolysaccharides; Liver Failure, Acute; Portal Vein; Random Allocation; Swine	2005
Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity. Journal of hepatology, 2006, Volume: 44, Issue:2 Topics: Animals; Apoptosis; Blotting, Western; Caspases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Galactosamine; Gene Expression; Interleukin-8; Liver; Liver Diseases; Male; Mice; Mice, Transgenic; NF-kappa B; RNA, Messenger; Transgenes; Tumor Necrosis Factor-alpha	2006
Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats. Journal of hepatology, 2006, Volume: 44, Issue:3 Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Follow-Up Studies; Galactosamine; Hepatocytes; Immunohistochemistry; Lipopolysaccharides; Liver Failure, Acute; Liver Regeneration; Male; Rats; Salvage Therapy; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A	2006
Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs. Journal of hepatology, 2006, Volume: 44, Issue:2 Topics: Animals; Bioreactors; Disease Models, Animal; Equipment Design; Galactosamine; Hemoperfusion; Hepatocytes; Liver Failure, Acute; Liver, Artificial; Male; Swine; Swine, Miniature; Textiles; Treatment Outcome	2006
Differential caspase-9-dependent signaling pathway between tumor necrosis factor receptor- and Fas-mediated hepatocyte apoptosis in mice. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:1 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Blotting, Western; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Enzyme Activation; fas Receptor; Galactosamine; Hepatocytes; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Random Allocation; Receptors, Tumor Necrosis Factor; Signal Transduction	2006
TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure. The Journal of surgical research, 2006, Volume: 134, Issue:2 Topics: Animals; Blood-Brain Barrier; Brain Edema; Collagenases; Dipeptides; Disease Models, Animal; Enzyme Inhibitors; Enzyme Precursors; Galactosamine; Injections, Intraperitoneal; Liver Failure, Acute; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1	2006
Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats. Critical care medicine, 2006, Volume: 34, Issue:3 Topics: Analysis of Variance; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fructosediphosphates; Galactosamine; Hepatocytes; Histamine Release; Immunologic Factors; Inflammation; Kupffer Cells; Liver Failure, Acute; Macrophage Activation; Potassium Channels; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha	2006
Prevention of lethal hepatic injury in Long-Evans Cinnamon (LEC) rats by D-galactosamine hydrochloride. The journal of medical investigation : JMI, 2006, Volume: 53, Issue:1-2 Topics: Animals; Disease Models, Animal; Free Radicals; Galactosamine; Hepatolenticular Degeneration; Humans; Liver; Male; Rats; Rats, Inbred LEC	2006
Protective effects of sugar cane extract on endotoxic shock in mice. Phytotherapy research : PTR, 2006, Volume: 20, Issue:5 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythrocytes; Female; Galactosamine; Hemorrhage; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Saccharum; Salmonella; Shock, Septic; Tumor Necrosis Factor-alpha	2006
The model of D-galactosamine-induced injury of rat hepatocytes in primary culture. Acta medica (Hradec Kralove), 2006, Volume: 49, Issue:1 Topics: Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatocytes; Male; Rats; Rats, Wistar	2006
Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. International journal of experimental pathology, 2006, Volume: 87, Issue:5 Topics: alpha-Fetoproteins; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatocytes; Liver Diseases; Liver Neoplasms, Experimental; Liver Regeneration; Male; Mice; Nitrosamines; Rats; Stem Cells	2006
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. The Journal of surgical research, 2007, Volume: 137, Issue:1 Topics: Adenoviridae; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Line, Transformed; Combined Modality Therapy; Disease Models, Animal; Extracorporeal Circulation; Female; Galactosamine; Genetic Therapy; Hepatocytes; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Interleukin-6; Liver; Liver Failure, Acute; Liver, Artificial; Male; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Survival Rate; Transfection; U937 Cells	2007
Characterization of the molecular mechanisms involved in the increased insulin secretion in rats with acute liver failure. Biochimica et biophysica acta, 2007, Volume: 1772, Issue:1 Topics: Alanine Transaminase; Animals; Blood Glucose; Disease Models, Animal; Galactosamine; Hyperinsulinism; Insulin; Insulin Secretion; Islets of Langerhans; Liver Failure, Acute; Male; Organ Size; Polypyrimidine Tract-Binding Protein; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation	2007
An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life sciences, 2007, Mar-13, Volume: 80, Issue:14 Topics: Alanine Transaminase; Animals; Anthracenes; Apoptosis; Aspartate Aminotransferases; bcl-Associated Death Protein; BH3 Interacting Domain Death Agonist Protein; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Enzyme Inhibitors; Galactosamine; Hepatocytes; Injections, Intraperitoneal; Injections, Subcutaneous; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Failure; Longevity; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Proto-Oncogene Proteins	2007
Amelioration of galactosamine-induced nephrotoxicity by a protein isolated from the leaves of the herb, Cajanus indicus L. BMC complementary and alternative medicine, 2007, Apr-25, Volume: 7 Topics: Animals; Biomarkers; Blood Urea Nitrogen; Cajanus; Creatinine; Disease Models, Animal; Galactosamine; Glutathione; Glutathione Reductase; Glutathione Transferase; Kidney Diseases; Lipid Peroxidation; Male; Mice; Oxidative Stress; Phytotherapy; Plant Extracts; Plant Leaves; Sulfhydryl Compounds; Superoxide Dismutase; Treatment Outcome	2007
Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. Journal of proteome research, 2007, Volume: 6, Issue:6 Topics: Animals; Blood Glucose; Disease Models, Animal; Galactosamine; Gas Chromatography-Mass Spectrometry; Gluconeogenesis; Glycolysis; Hydroxyindoleacetic Acid; Lipopolysaccharides; Liver Failure, Acute; Mice; Phosphates; Serum	2007
Type I inositol 1, 4, 5-triphosphate receptors increase in kidney of mice with fulminant hepatic failure. World journal of gastroenterology, 2007, Apr-28, Volume: 13, Issue:16 Topics: Animals; Calcium Channels; Disease Models, Animal; Disease Progression; Galactosamine; Glomerular Mesangium; Hepatorenal Syndrome; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Lipopolysaccharides; Liver Failure, Acute; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Up-Regulation	2007
Galactosamine-induced fulminant liver failure--observation in a porcine model. Asian journal of surgery, 2002, Volume: 25, Issue:1 Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Costs; Galactosamine; Liver Failure, Acute; Swine	2002
Inhibitory effect of dimethyl sulfoxide (DMSO) on necrosis and oxidative stress caused by D-galactosamine in the rat liver. Journal of nutritional science and vitaminology, 2007, Volume: 53, Issue:2 Topics: Alanine Transaminase; Analysis of Variance; Animals; Ascorbic Acid; Aspartate Aminotransferases; Blotting, Western; Dimethyl Sulfoxide; Disease Models, Animal; Free Radical Scavengers; Galactosamine; Liver; Male; Mitogen-Activated Protein Kinases; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Time Factors	2007
Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:9 Topics: Animals; Bifidobacterium; Blueberry Plants; Cecum; Dietary Supplements; Disease Models, Animal; Endotoxins; Galactosamine; Inflammation; Lactobacillus plantarum; Liver Failure, Acute; Probiotics; Rats	2007
Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine. Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:10 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Injections, Intravenous; Interferon-gamma; Lipopolysaccharides; Liver Failure, Acute; Male; Methylprednisolone Hemisuccinate; Portal Vein; Rats; Rats, Wistar; Survival Rate; Tumor Necrosis Factor-alpha	2007
Early growth response-1 contributes to galactosamine/lipopolysaccharide-induced acute liver injury in mice. American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 293, Issue:6 Topics: Animals; Disease Models, Animal; Early Growth Response Protein 1; Female; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Mice; Mice, Inbred C57BL	2007
Galactosamine-induced acute liver injury in rats reduces hepatic alpha-tocopherol transfer protein production. Journal of nutritional science and vitaminology, 2007, Volume: 53, Issue:4 Topics: Alanine Transaminase; alpha-Tocopherol; Animals; Aspartate Aminotransferases; Blotting, Western; Carrier Proteins; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models, Animal; Galactosamine; L-Lactate Dehydrogenase; Liver Diseases; Male; Phospholipids; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triglycerides	2007
Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats. The Journal of surgical research, 2008, Volume: 145, Issue:1 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Cytokines; Disease Models, Animal; Galactosamine; L-Lactate Dehydrogenase; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Neutrophil Infiltration; NF-kappa B; Nitric Oxide Synthase Type II; Proteinase Inhibitory Proteins, Secretory; Pyrroles; Rats; Rats, Sprague-Dawley	2008
N-acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Acta pharmacologica Sinica, 2007, Volume: 28, Issue:11 Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Lipopolysaccharides; Mice; Mice, Inbred Strains; Nitric Oxide; Tumor Necrosis Factor-alpha	2007
[Establishment of a D-galactosamine/lipopolysaccharide induced acute-on-chronic liver failure model in rats]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007, Volume: 15, Issue:10 Topics: Animals; Disease Models, Animal; Female; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Rats; Rats, Wistar; Serum Albumin	2007
TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax. Journal of immunology (Baltimore, Md. : 1950), 2007, Nov-15, Volume: 179, Issue:10 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cysteine Endopeptidases; Disease Models, Animal; Down-Regulation; Galactosamine; Hepatitis, Animal; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Transplantation; Mice; Mitochondria, Liver; Nuclear Proteins; Reperfusion Injury; RNA, Small Interfering; Transcription, Genetic; Transplantation Conditioning; Tumor Necrosis Factor alpha-Induced Protein 3; Tumor Necrosis Factors	2007
Intracranial pressure observations in a canine model of acute liver failure supported by a bioartificial liver support system. Artificial organs, 2007, Volume: 31, Issue:11 Topics: Animals; Disease Models, Animal; Dogs; Galactosamine; Intracranial Hypertension; Intracranial Pressure; Liver Failure, Acute; Liver, Artificial; Probability; Random Allocation; Reference Values; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate	2007
Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure. Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:8 Pt 2 Topics: Animals; Disease Models, Animal; Endotoxins; Galactosamine; Immunity, Innate; Lipopolysaccharide Receptors; Liver; Liver Failure, Acute; Lung; Male; Rats; Rats, Wistar; RNA, Messenger; Spleen; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2008
Effect of dietary fiber in edible seaweeds on the development of D-galactosamine-induced hepatopathy in rats. Journal of nutritional science and vitaminology, 2007, Volume: 53, Issue:5 Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Body Weight; Cecum; Chemical and Drug Induced Liver Injury; Dietary Fiber; Disease Models, Animal; Galactosamine; Intestines; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Neomycin; Rats; Rats, Wistar; Seaweed	2007
Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis. Journal of hepatology, 2008, Volume: 48, Issue:3 Topics: Animals; Antioxidants; Disease Models, Animal; Female; Galactosamine; Glutathione; Hepatitis; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred Strains; Mycobacterium bovis; NF-kappa B; Nitric Oxide; Pyrrolidines; Thiocarbamates; Tumor Necrosis Factor-alpha	2008
Mao (Ephedra sinica Stapf) protects against D-galactosamine and lipopolysaccharide-induced hepatic failure. Cytokine, 2008, Volume: 41, Issue:3 Topics: Animals; Apoptosis; Caspases; Cytokines; Disease Models, Animal; Ephedra sinica; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; STAT3 Transcription Factor; Tyrphostins	2008
Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2008, Volume: 57, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Pyridones; Rats; Rats, Sprague-Dawley; Severity of Illness Index	2008
Sialoadenectomy enhances hepatic injury induced by lipopolysaccharide/galactosamine in mice. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:6 Topics: Adrenal Glands; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Corticosterone; Disease Models, Animal; Drug Therapy, Combination; Galactosamine; Hepatocytes; Interleukin-6; Lipopolysaccharides; Liver; Male; Mice; Perfusion; Peroxidase; Submandibular Gland; Tumor Necrosis Factor-alpha	2008
Cytochrome c: a non-invasive biomarker of drug-induced liver injury. Journal of applied toxicology : JAT, 2008, Volume: 28, Issue:7 Topics: Acetaminophen; Acute Disease; Animals; Apoptosis; Biomarkers; Chemical and Drug Induced Liver Injury; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; Male; Mitochondria; Necrosis; Rats; Rats, Sprague-Dawley	2008
Preclinical models of hepatic encephalopathy. Current protocols in neuroscience, 2001, Volume: Chapter 9 Topics: Animals; Disease Models, Animal; Galactosamine; Hepatic Artery; Hepatic Encephalopathy; Hypertension, Portal; Ligation; Liver Failure; Male; Portacaval Shunt, Surgical; Postoperative Complications; Rats; Rats, Sprague-Dawley; Species Specificity; Suture Techniques; Thioacetamide	2001
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN. Thrombosis and haemostasis, 2008, Volume: 99, Issue:5 Topics: Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Count; Time Factors	2008
[Reproduction of the murine endotoxin shock model in D-galactosamine-sensitized KunMing mice]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2007, Volume: 23, Issue:6 Topics: Animals; Disease Models, Animal; Female; Galactosamine; Male; Mice; Mice, Inbred Strains; Serum; Shock, Septic; Tumor Necrosis Factor-alpha	2007
Enhanced expressions and activations of leukotriene C4 synthesis enzymes in D-galactosamine/lipopolysaccharide-induced rat fulminant hepatic failure model. World journal of gastroenterology, 2008, May-07, Volume: 14, Issue:17 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blotting, Western; Chromatography, High Pressure Liquid; Cysteine; Disease Models, Animal; Galactosamine; Glutathione Transferase; Immunohistochemistry; Isoenzymes; Leukotriene C4; Leukotrienes; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Up-Regulation	2008
Beneficial effect of somatostatin on galactosamine induced liver injury. Regulatory peptides, 1983, Volume: 7, Issue:3 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Male; Rats; Somatostatin	1983
[Insulin action: receptor binding and signal relay]. Medizinische Klinik, 1980, Apr-11, Volume: 75, Issue:8 Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Diabetes Mellitus; Disease Models, Animal; Galactosamine; Hepatitis, Animal; Humans; Insulin; Insulin Antagonists; Insulin Resistance; Middle Aged; Obesity; Rats; Receptor, Insulin	1980
Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. Science (New York, N.Y.), 1982, Apr-23, Volume: 216, Issue:4544 Topics: Bicuculline; Binding, Competitive; Brain; Disease Models, Animal; Galactosamine; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Kinetics; Receptors, Cell Surface; Receptors, GABA-A; Synaptic Membranes; Time Factors	1982
Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. The Journal of laboratory and clinical medicine, 1983, Volume: 102, Issue:6 Topics: Animals; Coma; Disease Models, Animal; Female; Flunitrazepam; Galactosamine; Hepatic Encephalopathy; Male; Membrane Proteins; Rabbits; Receptors, Cell Surface; Receptors, GABA-A; Synaptic Membranes; Uremia	1983
Amino acid disturbances in experimental hepatic coma rats. The International journal of artificial organs, 1984, Volume: 7, Issue:4 Topics: Amino Acids; Amino Acids, Branched-Chain; Animals; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains	1984
Effect of charcoal hemoperfusion on amino acid disturbance in experimental hepatic coma. The International journal of artificial organs, 1984, Volume: 7, Issue:4 Topics: Adsorption; Amino Acids; Amino Acids, Branched-Chain; Animals; Charcoal; Chromatography, High Pressure Liquid; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains; Time Factors	1984
Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. Gastroenterology, 1984, Volume: 86, Issue:3 Topics: Animals; Diazepam; Disease Models, Animal; Electrodes; Electroencephalography; Evoked Potentials, Visual; Galactosamine; Hepatic Encephalopathy; Muscimol; Pentobarbital; Rabbits	1984
Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Gastroenterology, 1984, Volume: 86, Issue:3 Topics: Ammonia; Animals; Caprylates; Disease Models, Animal; Disulfides; Evoked Potentials, Visual; Galactosamine; Hepatic Encephalopathy; Rabbits; Seizures	1984
[Preliminary observations on D-galactosamine-induced hepatic failure in rat models (author's transl)]. Zhonghua yi xue za zhi, 1981, Volume: 61, Issue:6 Topics: Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Rats	1981
Mannitol treatment of cerebral edema in rats with galactosamine-induced severe hepatitis. Experientia, 1981, Dec-15, Volume: 37, Issue:12 Topics: Animals; Brain Edema; Disease Models, Animal; Female; Galactosamine; Hepatitis; Mannitol; Prognosis; Rats; Rats, Inbred Strains	1981
Sensitivity of serum glutamic oxaloacetic transaminase and bile acid levels for the detection of experimental liver injury in rats. Journal of medicine, 1981, Volume: 12, Issue:4 Topics: Animals; Aspartate Aminotransferases; Bile Acids and Salts; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Disease Models, Animal; Galactosamine; Liver Diseases; Male; Rats; Rats, Inbred Strains	1981
Reversal of experimental acute hepatic failure in the rat. The Journal of surgical research, 1980, Volume: 29, Issue:6 Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic	1980
Cellular transplantation in the treatment of experimental hepatic failure. Science (New York, N.Y.), 1980, Nov-21, Volume: 210, Issue:4472 Topics: Animals; Bone Marrow Transplantation; Disease Models, Animal; Galactosamine; Hepatectomy; Hypoxia; Liver; Liver Diseases; Liver Transplantation; Necrosis; Rats; Transplantation, Homologous	1980
Endotoxin-induced hyperinsulinemia and hyperglucagonemia after experimental liver injury. The American journal of physiology, 1981, Volume: 241, Issue:6 Topics: Animals; Carbon Tetrachloride Poisoning; Disease Models, Animal; Endotoxins; Galactosamine; Glucagon; Hepatectomy; Hyperinsulinism; Liver Diseases; Male; Rats; Salmonella enteritidis	1981
[Modelling of acute liver failure in rabbits]. Biulleten' eksperimental'noi biologii i meditsiny, 1982, Volume: 93, Issue:6 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Rabbits; Time Factors	1982
Pathological study of chronic D-galactosamine induced hepatitis in mice by administration of adjuvants - an animal model of the chronic active hepatitis. Gastroenterologia Japonica, 1981, Volume: 16, Issue:1 Topics: Adjuvants, Immunologic; Animals; Blood Proteins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Mice; Mice, Inbred C57BL; Necrosis; Organ Size; Spleen	1981
Middle molecules in hepatic coma and uremia. Artificial organs, 1981, Volume: 4 Suppl Topics: Animals; Blood Chemical Analysis; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Humans; Kidney Failure, Chronic; Rats; Reference Values; Toxins, Biological; Uremia	1981
Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7 Topics: Animals; Bacteremia; Dextrans; Disease Models, Animal; Drug Carriers; Endotoxins; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipopolysaccharides; Mice; Polymyxin B; Toxemia	1995
Transplantation of microencapsulated hepatocytes for liver function replacement. Journal of biomaterials science. Polymer edition, 1995, Volume: 7, Issue:4 Topics: Animals; Artificial Organs; Biodegradation, Environmental; Cell Membrane Permeability; Cell Survival; Cell Transplantation; Cryopreservation; Disease Models, Animal; Drug Compounding; Galactosamine; Hepatic Encephalopathy; Immunosuppression Therapy; Liver; Liver Diseases; Liver Function Tests; Male; Rats; Rats, Wistar	1995
Brain somatostatin receptors in a rat model of acute liver failure. Synapse (New York, N.Y.), 1995, Volume: 20, Issue:2 Topics: Adenylyl Cyclases; Animals; Brain; Disease Models, Animal; Frontal Lobe; Galactosamine; Hippocampus; Injections, Intraperitoneal; Kinetics; Liver Failure, Acute; Rats; Rats, Wistar; Receptors, Somatostatin	1995
The evaluation of hepatoprotective effects of Taiwan folk medicine 'teng-khia-u'. Journal of ethnopharmacology, 1995, Volume: 45, Issue:2 Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Division; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Lymphocytes; Male; Medicine, Traditional; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Taiwan	1995
Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis. The Journal of infectious diseases, 1995, Volume: 171, Issue:1 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Blood Bactericidal Activity; Blood Proteins; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Galactosamine; Lipopolysaccharides; Male; Membrane Proteins; Mice; Recombinant Proteins; Sepsis; Tumor Necrosis Factor-alpha	1995
Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation. The Journal of laboratory and clinical medicine, 1994, Volume: 124, Issue:6 Topics: Animals; Carrageenan; Disease Models, Animal; Female; Foot; Galactosamine; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Shock, Septic; Survival Analysis; Tissue Distribution; Tumor Necrosis Factor-alpha	1994
Differential antibiotic-induced release of endotoxin from gram-negative bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13 Suppl 1 Topics: Animals; Ceftazidime; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipid A; Lipopolysaccharides; Mice; Microbial Sensitivity Tests	1994
An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:3 Topics: Anesthesia; Animals; Disease Models, Animal; Dogs; Galactosamine; Halothane; Hepatic Encephalopathy; Liver; Male	1995
Hepatoprotective effects of Taiwan folk medicine: wedelia chinensis on three hepatotoxin-induced hepatotoxicity. The American journal of Chinese medicine, 1994, Volume: 22, Issue:2 Topics: Acetaminophen; Acute Disease; Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs, Chinese Herbal; Galactosamine; Liver; Male; Mice; Mice, Inbred ICR; Microscopy, Fluorescence; Paraffin Embedding; Random Allocation; Rats; Rats, Wistar; Taiwan	1994
Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:1 Topics: Animals; Benzoquinones; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endotoxins; Galactosamine; Lipopolysaccharides; Male; Propionates; Rats; Rats, Inbred F344	1993
IL-12 rescues galactosamine-loaded mice from lethal shock triggered by staphylococcal enterotoxin. Biochemical and biophysical research communications, 1995, Dec-05, Volume: 217, Issue:1 Topics: Animals; Cytokines; Disease Models, Animal; Enterotoxins; Galactosamine; Gene Expression; Injections, Intraperitoneal; Interleukin-12; Lymphoid Tissue; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; RNA, Messenger; Shock, Septic; Species Specificity; Staphylococcus aureus; Superantigens; T-Lymphocytes	1995
Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infection and immunity, 1996, Volume: 64, Issue:3 Topics: Animals; Apoptosis; Disease Models, Animal; DNA; Female; Galactosamine; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Rabbits; Shock, Septic; Tumor Necrosis Factor-alpha	1996
Differential effects of malnutrition, bile duct ligation and galactosamine injection in young rats on serum levels and gene expression of IGF-binding proteins. The Journal of endocrinology, 1996, Volume: 149, Issue:3 Topics: Animals; Base Sequence; Bile Ducts; Blotting, Northern; Disease Models, Animal; DNA Primers; Galactosamine; Gene Expression; Immunoblotting; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Ligation; Liver; Liver Diseases; Male; Molecular Sequence Data; Nutrition Disorders; Polymerase Chain Reaction; Rats; Rats, Wistar	1996
Bacterial translocation in D-galactosamine-treated rats in a burn model. Burns : journal of the International Society for Burn Injuries, 1996, Volume: 22, Issue:1 Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bacterial Translocation; Burns; Colony Count, Microbial; Cytokines; Disease Models, Animal; Escherichia coli; Galactosamine; Lipopolysaccharides; Male; Neomycin; Rats; Rats, Wistar; Specific Pathogen-Free Organisms; Tissue Distribution; Wound Infection	1996
Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease. Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:6 Topics: Administration, Oral; Animals; Antiviral Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Gastric Emptying; Glycyrrhetinic Acid; Glycyrrhizic Acid; Injections, Intravenous; Intestinal Absorption; Liver Diseases; Male; Rats; Rats, Wistar	1996
Immunohistochemical study of proteoglycans in D-galactosamine-induced acute liver injury in rats. Journal of gastroenterology, 1996, Volume: 31, Issue:1 Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Galactosamine; Heparitin Sulfate; Immunohistochemistry; Liver; Liver Diseases; Male; Microscopy, Electron; Proliferating Cell Nuclear Antigen; Proteoglycans; Rats; Rats, Sprague-Dawley	1996
Induction and prevention of shock-like lethal side effects after microfilaricidal treatment in filariae infected rodents. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ), 1995, Volume: 46, Issue:4 Topics: Animals; Brugia malayi; Disease Models, Animal; Enterotoxins; Filariasis; Filarioidea; Galactosamine; Lipopolysaccharides; Muridae	1995
DNA fragmentation in mouse organs during endotoxic shock. The American journal of pathology, 1996, Volume: 149, Issue:4 Topics: Animals; Apoptosis; Disease Models, Animal; DNA Fragmentation; Female; Galactosamine; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Microscopy, Electron; Necrosis; Nitric Oxide; Protein Biosynthesis; Shock, Septic; Time Factors; Transcription, Genetic; Tumor Necrosis Factor-alpha	1996
Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Infection and immunity, 1997, Volume: 65, Issue:2 Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Bacteremia; Cross Reactions; Disease Models, Animal; Endotoxemia; Epitopes; Escherichia coli Infections; Female; Galactosamine; Lipopolysaccharides; Mice	1997
Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:4 Topics: Anesthesia; Animals; Artificial Organs; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Female; Galactosamine; Liver; Liver Failure; Male; Necrosis	1997
Inhibition of nitric oxide modulates the effect of oral arginine supplementation in acute liver injury. Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:8 Topics: Acute Disease; Administration, Oral; Alanine Transaminase; Analysis of Variance; Animals; Arginine; Aspartate Aminotransferases; Bacterial Translocation; Bilirubin; Chemical and Drug Induced Liver Injury; Colony Count, Microbial; Disease Models, Animal; DNA; Enzyme Inhibitors; Food, Fortified; Galactosamine; Intestinal Mucosa; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; RNA	1997
Comparative study of oral and parenteral administration of sho-saiko-to (xiao-chaihu-tang) extract on D-galactosamine-induced liver injury in rats. The American journal of Chinese medicine, 1997, Volume: 25, Issue:3-4 Topics: 5'-Nucleotidase; Administration, Oral; Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs, Chinese Herbal; Galactosamine; Glucose-6-Phosphatase; Hypolipidemic Agents; Injections, Intraperitoneal; Liver Diseases; Male; Rats; Rats, Wistar; Serum Albumin; Triglycerides	1997
Galactosamine-induced fulminant hepatic failure. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:5 Topics: Animals; Disease Models, Animal; Dogs; Galactosamine; Liver Failure	1997
Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. Journal of immunology (Baltimore, Md. : 1950), 1998, Apr-01, Volume: 160, Issue:7 Topics: Animals; Apoptosis; Bacterial Toxins; Caspase 3; Caspases; Cysteine Endopeptidases; Disease Models, Animal; Endotoxins; Enzyme Activation; Galactosamine; Liver; Male; Mice; Mice, Inbred C3H; Necrosis; Neutrophils; Salmonella; Shock, Septic; Time Factors; Tumor Necrosis Factor-alpha	1998
LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. The Journal of clinical investigation, 1998, May-15, Volume: 101, Issue:10 Topics: Acute-Phase Proteins; Animals; Carrier Proteins; Cell Line; Cytokines; Disease Models, Animal; Galactosamine; Gram-Negative Bacteria; Lipopolysaccharides; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Peritonitis; Polysaccharides, Bacterial; Recombinant Proteins; Salmonella; Shock, Septic	1998
Altered expression of constitutive type and inducible type heat shock proteins in response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. FEMS immunology and medical microbiology, 1998, Volume: 21, Issue:1 Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Chaperonin 60; Disease Models, Animal; Female; Galactosamine; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Immune Sera; Immunohistochemistry; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Recombinant Proteins; Shock, Septic; Tumor Necrosis Factor-alpha	1998
Carcinoembryonic antigen-related cell-cell adhesion molecule C-CAM is greatly increased in serum and urine of rats with liver diseases. FEBS letters, 1998, Oct-30, Volume: 438, Issue:1-2 Topics: Animals; Antigens, CD; Bile; Bile Ducts; Blotting, Western; Cadherins; Carcinoembryonic Antigen; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Disease Models, Animal; Galactosamine; Galactose; Glycoproteins; Hepatitis, Animal; Ligation; Liver Neoplasms, Experimental; Membrane Glycoproteins; Membrane Transport Proteins; Rats; Rats, Inbred BUF; Rats, Wistar	1998
Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infection and immunity, 1999, Volume: 67, Issue:3 Topics: Animals; Disease Models, Animal; Female; Galactosamine; Heat-Shock Proteins; Lipopolysaccharides; Liver; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rabbits; RNA, Messenger; Shock, Septic; Tumor Necrosis Factor-alpha; Tyrosine	1999
Caspase-1 is not involved in experimental hepatitis in mouse. FEBS letters, 1999, Feb-19, Volume: 445, Issue:1 Topics: Animals; Caspase 1; Disease Models, Animal; DNA Fragmentation; fas Receptor; Female; Galactosamine; Hepatitis; Interleukin-1; Lipopolysaccharides; Mice; Mice, Knockout; Tumor Necrosis Factor-alpha	1999
An improved model of galactosamine-induced fulminant hepatic failure in the pig. The Journal of surgical research, 1999, Volume: 82, Issue:2 Topics: Animals; Blood Coagulation Tests; Brain; Disease Models, Animal; Galactosamine; Liver; Liver Failure; Liver Function Tests; Male; Swine	1999
Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats. Phytotherapy research : PTR, 1999, Volume: 13, Issue:2 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Liver Diseases; Liver Function Tests; Male; Phytotherapy; Plant Extracts; Rats	1999
LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. American journal of respiratory and critical care medicine, 1999, Volume: 159, Issue:4 Pt 1 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Escherichia coli; Female; Galactosamine; Hepatitis, Animal; Immunization; In Situ Nick-End Labeling; Interleukin-1; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Shock, Septic; Tumor Necrosis Factor-alpha	1999
Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock. Microbial pathogenesis, 1999, Volume: 27, Issue:2 Topics: Animals; Bacterial Toxins; Blotting, Southern; Disease Models, Animal; Enterotoxins; Female; Galactosamine; Humans; Mice; Mice, Inbred BALB C; Plasmids; Recombination, Genetic; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Virulence	1999
A mouse model utilising human transferrin to study protection against Neisseria meningitidis serogroup B induced by outer membrane vesicle vaccination. FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:1 Topics: Animals; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Galactosamine; Humans; Iron; Meningitis, Meningococcal; Mice; Mice, Congenic; Neisseria meningitidis; Survival Rate; Transferrin	1999
Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. Journal of immunology (Baltimore, Md. : 1950), 1999, Dec-15, Volume: 163, Issue:12 Topics: Animals; Blood Cell Count; Concanavalin A; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Female; Galactosamine; Interferon Regulatory Factor-1; Interferon-gamma; Lipopolysaccharides; Lymph Nodes; Lymphocyte Count; Malaria, Cerebral; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphoproteins; RNA, Messenger; Spleen; Splenectomy; Survival Rate; Tumor Necrosis Factor-alpha	1999
Tumor necrosis factor-induced lethal hepatitis: pharmacological intervention with verapamil, tannic acid, picotamide and K76COOH. FEBS letters, 2000, Feb-11, Volume: 467, Issue:2-3 Topics: Alanine Transaminase; Animals; Apoptosis; Astringents; Chemical and Drug Induced Liver Injury; Complement Inactivator Proteins; Dactinomycin; Disease Models, Animal; Galactosamine; Hydrolyzable Tannins; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phthalic Acids; Platelet Aggregation Inhibitors; Sesquiterpenes; Tumor Necrosis Factor-alpha; Verapamil	2000
LCC, a cerebroside from Lycium chinense, protects primary cultured rat hepatocytes exposed to galactosamine. Phytotherapy research : PTR, 2000, Volume: 14, Issue:6 Topics: Animals; Cells, Cultured; Cerebrosides; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; Male; Plant Extracts; Rats; Rats, Wistar; Solanaceae	2000
Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2000, Volume: 14, Issue:13 Topics: Animals; Apoptosis; Cell Division; Disease Models, Animal; Galactosamine; Humans; Interleukin-6; Liver Failure; Liver Regeneration; Male; Rats; Rats, Inbred F344; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Thioacetamide	2000
Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. Artificial organs, 2001, Volume: 25, Issue:2 Topics: Animals; Disease Models, Animal; Female; Galactosamine; Hepatic Encephalopathy; Liver Failure, Acute; Liver Regeneration; Liver, Artificial; Perfusion; Plasma; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Treatment Outcome	2001
1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock. The Journal of pharmacy and pharmacology, 2001, Volume: 53, Issue:4 Topics: Animals; Cyclohexanols; Disease Models, Animal; Eucalyptol; Galactosamine; Lipopolysaccharides; Liver Failure; Male; Menthol; Mice; Monoterpenes; Shock, Septic; Solvents; Terpenes; Transaminases; Tumor Necrosis Factor-alpha	2001
A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha. Digestive diseases and sciences, 2001, Volume: 46, Issue:8 Topics: Animals; Disease Models, Animal; Galactosamine; Interleukin-1; Liver; Liver Failure; Male; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha	2001
Animal models of fulminant hepatic failure: need to test liver support devices. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:7 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Dogs; Galactosamine; Hepatectomy; Humans; Liver Failure; Liver Transplantation; Liver, Artificial; Swine	2001
4-Nitrobenzylidene malononitrile reduces apoptosis-mediated liver injury in mice. Journal of hepatology, 2002, Volume: 36, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Disease Models, Animal; Enzyme Inhibitors; Female; Galactosamine; Hepatocytes; In Situ Nick-End Labeling; Liver Diseases; Mice; Mice, Inbred BALB C; Transaminases; Tumor Necrosis Factor-alpha; Tyrphostins	2002
[The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)]. Aktuelle Gerontologie, 1976, Volume: 6, Issue:6 Topics: Age Factors; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Humans; Prednisolone; Rats	1976
Serum alpha-fetoprotein. A prognostic indicator of liver-cell necrosis and regeneration following experimental injury by galactosamine in rats. American journal of clinical pathology, 1976, Volume: 66, Issue:5 Topics: Alanine Transaminase; Alkaline Phosphatase; alpha-Fetoproteins; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatitis, Viral, Human; Humans; Liver; Liver Regeneration; Male; Necrosis; Prognosis; Rats; Time Factors	1976
An animal model of fulminant hepatic failure in the rat. Acta medica Okayama, 1979, Volume: 33, Issue:6 Topics: Amino Acids; Animals; Brain; Brain Chemistry; Brain Edema; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Liver; Liver Diseases; Male; Rats	1979
Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplantation proceedings, 1979, Volume: 11, Issue:1 Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Rats	1979
Inhibition of galactosamine induced edemas in the rat by drugs preventing macromolecular leakage from the hamster cheek pouch microvasculature. Bibliotheca anatomica, 1979, Issue:18 Topics: Animals; Capillary Permeability; Cheek; Cricetinae; Dextrans; Dimethindene; Disease Models, Animal; Edema; Galactosamine; Macromolecular Substances; Microcirculation; Rats; Terbutaline	1979
An experimental model of osteoarthritis; early morphological and biochemical changes. The Journal of bone and joint surgery. British volume, 1977, Volume: 59, Issue:1 Topics: Animals; Bone Development; Cartilage, Articular; Chondroitin Sulfates; Disease Models, Animal; Dogs; Female; Femur; Galactosamine; Glucosamine; Keratan Sulfate; Knee Joint; Ligaments, Articular; Male; Menisci, Tibial; Osteoarthritis; Proteoglycans; Stress, Physiological; Synovial Membrane; Tibia; Uronic Acids	1977
Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure. Artificial organs, 1977, Volume: 1, Issue:1 Topics: Albumins; Animals; Artificial Organs; Charcoal; Collodion; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Rats	1977
A model of fulminant hepatic failure in the rabbit. Gastroenterology, 1978, Volume: 74, Issue:4 Topics: Alkaline Phosphatase; Amino Acids; Ammonia; Animals; Aspartate Aminotransferases; Blood Coagulation Tests; Blood Glucose; Creatinine; Disease Models, Animal; Electroencephalography; Galactosamine; Hepatic Encephalopathy; L-Lactate Dehydrogenase; Liver; Rabbits	1978
Cerebral edema in the rat with galactosamine induced severe hepatitis. Experientia, 1978, Nov-15, Volume: 34, Issue:11 Topics: Animals; Brain Edema; Brain Stem; Cerebellum; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Rats; Time Factors; Water	1978
Lipoprotein abnormalities in galactosamine hepatitis: a model of experimental lecithin:cholesterol acyltransferase deficiency. Scandinavian journal of clinical and laboratory investigation. Supplementum, 1978, Volume: 150 Topics: Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Cholesterol; Cholesterol Esters; Disease Models, Animal; Female; Galactosamine; Hypolipoproteinemias; Lecithin Cholesterol Acyltransferase Deficiency; Lipids; Lipoproteins; Lysophosphatidylcholines; Phosphatidylcholines; Phospholipids; Rats	1978
Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury. Science (New York, N.Y.), 1975, Dec-26, Volume: 190, Issue:4221 Topics: Acyltransferases; Animals; Apoproteins; Chemical and Drug Induced Liver Injury; Cholesterol Esters; Disease Models, Animal; Female; Galactosamine; Lecithin Cholesterol Acyltransferase Deficiency; Lipid Metabolism, Inborn Errors; Lipoproteins; Liver Diseases; Phosphatidylcholine-Sterol O-Acyltransferase; Rats	1975
Protective effect of ammonium ions and L-norvaline on galactosamine induced liver injury. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1977, Volume: 358, Issue:5 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Female; Galactosamine; Glutamate Dehydrogenase; Liver; Liver Diseases; Ornithine Carbamoyltransferase; Quaternary Ammonium Compounds; Rats; Uracil Nucleotides	1977
[(Blood coagulation disturbances of rats after acute liver damage produced by D-galactosamin-HCl) (author's transl)]. Zeitschrift fur Gastroenterologie, 1977, Volume: 15, Issue:8 Topics: Animals; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Fibrinolysis; Galactosamine; Hematocrit; Hemostasis; Liver Diseases; Platelet Aggregation; Rats	1977
Light and electron microscopic study of hermorrhagic hepatitis induced by trimethyllysine and D-galactosamine. Experimentelle Pathologie, 1977, Volume: 13, Issue:2-3 Topics: Animals; Cell Division; Chemical and Drug Induced Liver Injury; Disease Models, Animal; DNA; Endoplasmic Reticulum; Galactosamine; Hemorrhage; Hepatitis; Liver Regeneration; Lysine; Mice; Microscopy, Electron; RNA	1977
[Advantages and limitations of the galactosamine model]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 1 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Gluconeogenesis; Glycolipids; Glycoproteins; Liver; Rats; RNA; Uracil Nucleotides	1976
[Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 1 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Isoniazid; Liver; Male; Rats; Rifampin	1976
An investigation and some parameters that affect the galactosamine model of hepatitis in the rat. Arzneimittel-Forschung, 1975, Volume: 25, Issue:6 Topics: Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Body Weight; Chemical and Drug Induced Liver Injury; Diethylstilbestrol; Disease Models, Animal; Dose-Response Relationship, Drug; Estrus; Female; Galactosamine; Injections, Intraperitoneal; Injections, Subcutaneous; L-Lactate Dehydrogenase; Male; Pregnancy; Rats; Sex Factors; Species Specificity; Time Factors	1975
An investigation of the hepatotoxicity of D-galactosamine in different species of animal. Arzneimittel-Forschung, 1975, Volume: 25, Issue:10 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Liver; Male; Mice; Rats; Species Specificity; Time Factors	1975
Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation. The American journal of pathology, 1976, Volume: 82, Issue:2 Topics: Alanine Transaminase; Aminocaproates; Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Female; Galactosamine; Heparin; Hepatitis; Kidney Cortex Necrosis; Kidney Glomerulus; Liver; Male; Rabbits	1976
Changes in chromatin during the development of liver cell injury induced by galactosamine. FEBS letters, 1976, Apr-15, Volume: 64, Issue:1 Topics: Animals; Cell Nucleus; Chromatin; Disease Models, Animal; Galactosamine; Hepatitis A; Hepatitis, Animal; Liver; Male; Nucleoproteins; Rats; RNA	1976
[The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats]. Biulleten' eksperimental'noi biologii i meditsiny, 1992, Volume: 114, Issue:11 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug Evaluation, Preclinical; Galactosamine; Liver; Male; Microscopy, Electron; Rats; Ubiquinone	1992
Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infection and immunity, 1992, Volume: 60, Issue:4 Topics: Animals; Antigens, Bacterial; Antigens, Surface; Bacteroides Infections; Cross Reactions; Cytotoxicity, Immunologic; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Immunologic; Enzyme-Linked Immunosorbent Assay; Female; Galactosamine; Immunization; Immunoglobulin G; Immunoglobulin M; Lipopolysaccharides; Membrane Proteins; Mice; Mice, Inbred BALB C; Neutrophils; Porphyromonas gingivalis; Vaccination; Vaccines, Inactivated; Virulence	1992
Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock. Circulatory shock, 1992, Volume: 37, Issue:4 Topics: Animals; Cytokines; Disease Models, Animal; Galactosamine; Humans; Imidazoles; In Vitro Techniques; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Monocytes; Propionibacterium acnes; Shock, Septic; Tumor Necrosis Factor-alpha	1992
The role of leukotriene D4 in septic shock models. Eicosanoids, 1992, Volume: 5 Suppl Topics: Animals; Cell Death; Cells, Cultured; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Failure; Mice; Shock, Septic; SRS-A; Tumor Necrosis Factor-alpha	1992
[Effects of green tea extract on galactosamine-induced hepatic injury in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1992, Volume: 100, Issue:5 Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Cytochrome P-450 Enzyme System; Depression, Chemical; Disease Models, Animal; Galactosamine; Hepatitis, Viral, Human; Liver; Male; Phosphatidylcholine-Sterol O-Acyltransferase; Plant Extracts; Rats; Rats, Wistar; Tea	1992
Effectivity and safety of mannitol treatment for acute hepatic failure in rats. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1992, Volume: 192, Issue:6 Topics: Animals; Biological Transport; Blood-Brain Barrier; Body Water; Brain; Brain Edema; Disease Models, Animal; Galactosamine; Liver Failure, Acute; Male; Mannitol; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Survival Rate	1992
Hepatic D-galactosamine toxicity studied with localized in vivo 31P magnetic resonance spectroscopy in intact rats. Magnetic resonance in medicine, 1991, Volume: 21, Issue:2 Topics: Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Liver Diseases; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphoric Diester Hydrolases; Phosphoric Monoester Hydrolases; Phosphorus; Rats; Rats, Inbred Strains	1991
Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1991, Volume: 19, Issue:3 Topics: Animals; Cell-Free System; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; DNA; Galactosamine; Growth Inhibitors; Interleukin-6; Leukemia Inhibitory Factor; Liver; Liver Diseases; Liver Regeneration; Lymphokines; Male; Rats; Rats, Inbred Strains; Survival Rate; Thymidine	1991
Physicochemical characteristics of hepatic stimulatory factor prepared from cell free supernatant of hepatocyte cultures. Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1991, Volume: 19, Issue:3 Topics: Acrylic Resins; Autoradiography; Calibration; Cell-Free System; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chromatography, Gel; Disease Models, Animal; DNA; Galactosamine; Growth Inhibitors; Hot Temperature; Interleukin-6; Leukemia Inhibitory Factor; Liver; Liver Diseases; Liver Regeneration; Lymphokines; Molecular Weight; Proteins; Survival Rate; Thymidine; Trypsin	1991
Hepatoprotective effects of 1-[(2-thiazolin-2-yl)-amino]acetyl-4-(1,3-dithiol-2-ylidene)-2,3,4,5- tetrahydro-1H-1-benzazepin-3,5-dione hydrochloride (KF-14363) in various experimental liver injuries. Japanese journal of pharmacology, 1991, Volume: 57, Issue:2 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzazepines; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Ethionine; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Propionibacterium acnes; Rats; Rats, Inbred Strains; Thiazoles; Triglycerides	1991
Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival. Infection and immunity, 1991, Volume: 59, Issue:8 Topics: Animals; Antibodies; Carrageenan; Disease Models, Animal; Drug Resistance; Drug Tolerance; Female; Galactosamine; Interleukin-6; Kinetics; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Shock, Septic; Survival Rate; Tumor Necrosis Factor-alpha	1991
Endotoxin-inducible cytotoxicity in liver cell cultures--I. Biochemical pharmacology, 1991, Aug-08, Volume: 42, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endotoxins; Galactosamine; Kupffer Cells; L-Lactate Dehydrogenase; Lipopolysaccharides; Liver; Male; Rats; Rats, Inbred Strains; Tumor Necrosis Factor-alpha	1991
The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand. Advances in biochemical psychopharmacology, 1990, Volume: 46 Topics: Animals; Autoradiography; Brain Chemistry; Disease Models, Animal; GABA-A Receptor Antagonists; Galactosamine; Hepatic Encephalopathy; Ligands; Rabbits; Receptors, GABA-A	1990
Alterations in Fc receptor activity in sinusoidal endothelial cells and Kupffer cells during D-galactosamine (GalN)-induced liver injury in rats. A histological study. Virchows Archiv. B, Cell pathology including molecular pathology, 1990, Volume: 58, Issue:6 Topics: Animals; Antigen-Antibody Complex; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Immunohistochemistry; Liver; Male; Peroxidase; Rats; Rats, Inbred Strains; Receptors, Fc	1990
Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary. The Journal of experimental medicine, 1991, Feb-01, Volume: 173, Issue:2 Topics: Animals; Blood Glucose; Corticosterone; Disease Models, Animal; Drug Hypersensitivity; Endotoxins; Female; Galactosamine; Hydrazines; Hypophysectomy; Immunization; Liver; Mice; Mice, Inbred C3H; Phosphoenolpyruvate Carboxykinase (GTP); Pituitary Gland; Premedication; Triiodothyronine; Tumor Necrosis Factor-alpha	1991
Deposition of IgA is associated with macrophage influx in the kidney of rats. Scandinavian journal of immunology, 1991, Volume: 34, Issue:1 Topics: Animals; Complement C3; Dimethylnitrosamine; Disease Models, Animal; Fluorescent Antibody Technique; Galactosamine; Glomerulonephritis, IGA; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Macrophages; Male; Rats; Rats, Inbred Strains	1991
Hepatoprotective activity of andrographolide against galactosamine & paracetamol intoxication in rats. The Indian journal of medical research, 1990, Volume: 92 Topics: Acetaminophen; Animals; Disease Models, Animal; Diterpenes; Female; Galactosamine; Hepatitis, Animal; Liver; Liver Function Tests; Male; Naphthols; Plant Extracts; Rats	1990
Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology, 1990, Volume: 98, Issue:3 Topics: Animals; Brain; Butanols; Carbon Radioisotopes; Disease Models, Animal; Galactosamine; gamma-Aminobutyric Acid; Half-Life; Hepatic Encephalopathy; Indium Radioisotopes; Methods; Rabbits; Time Factors; Transferrin; Tritium	1990
[Hepatocyte transplantation - development of a clinical model]. Zeitschrift fur Gastroenterologie. Verhandlungsband, 1987, Volume: 22 Topics: Animals; Cell Separation; Cell Survival; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Histocytochemistry; Injections; Injections, Intraperitoneal; Liver; Liver Diseases; Liver Transplantation; Rats; Rats, Inbred Strains; Spleen; Swine; Transplantation	1987
Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action. Circulatory shock, 1989, Volume: 27, Issue:1 Topics: Animals; Arachidonic Acid; Arachidonic Acids; Dexamethasone; Disease Models, Animal; Galactosamine; Imidazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Propionibacterium acnes; Shock, Septic; Thiazoles; Tumor Necrosis Factor-alpha	1989
Colchicine prevents D-galactosamine-induced hepatitis. Journal of hepatology, 1989, Volume: 8, Issue:2 Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Calcium; Calcium-Transporting ATPases; Chemical and Drug Induced Liver Injury; Colchicine; Disease Models, Animal; Galactosamine; gamma-Glutamyltransferase; Glycogen; Lipid Peroxidation; Liver; Male; Rats; Rats, Inbred Strains	1989
Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury. Growth factors (Chur, Switzerland), 1989, Volume: 1, Issue:3 Topics: Acute Disease; Animals; Blotting, Northern; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Immunoenzyme Techniques; Male; Rats; Rats, Inbred Strains; RNA, Messenger; Transcription, Genetic; Transforming Growth Factors; Tumor Necrosis Factor-alpha	1989
Effect of macrophage inhibition in carrageenan- and D-galactosamine-induced sensitivity to low-dose endotoxin. Progress in clinical and biological research, 1989, Volume: 286 Topics: Animals; Carrageenan; Disease Models, Animal; Drug Synergism; Female; Galactosamine; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Reference Values; Shock, Septic	1989
Correlation between electroencephalographic and biochemical indices in acute hepatic encephalopathy in rats. Journal of hepatology, 1987, Volume: 4, Issue:3 Topics: Acute Disease; Alanine Transaminase; Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroencephalography; Galactosamine; Hepatic Encephalopathy; Humans; Rats; Rats, Inbred Strains	1987
[Galactosamine-induced acute liver failure in the guinea pig--spontaneous course and controlled study conditions]. Zeitschrift fur Gastroenterologie, 1986, Volume: 24, Issue:4 Topics: Acute Disease; Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Guinea Pigs; Hepatic Encephalopathy; Liver; Liver Function Tests; Male; Necrosis	1986
Chronic liver disease animal model for evaluation of artificial liver support systems. Transactions - American Society for Artificial Internal Organs, 1985, Volume: 31 Topics: Animals; Body Weight; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Galactosamine; Hepatitis, Chronic; Liver Diseases; Male; Necrosis; Partial Thromboplastin Time; Prothrombin Time	1985
Effect of coenzyme-A, NAD, alpha lipoic-acid and cocarboxylase on survival of rats with galactosamine-induced severe hepatitis. Experientia, 1985, Aug-15, Volume: 41, Issue:8 Topics: Animals; Coenzyme A; Disease Models, Animal; Female; Galactosamine; Hepatitis; Liver Function Tests; NAD; Rats; Rats, Inbred Strains; Thiamine Pyrophosphate; Thioctic Acid	1985
[Substance-induced liver injury as a model for evaluating hepatoprotective drugs]. Casopis lekaru ceskych, 1985, Feb-08, Volume: 124, Issue:6 Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug Evaluation, Preclinical; Galactosamine; Liver Diseases; Rabbits; Rats; Rats, Inbred Strains; Thioacetamide	1985
Effects of regenerating liver cytosol on drug-induced hepatic failure. Surgery, 1985, Volume: 97, Issue:4 Topics: Animals; Bilirubin; Blood Glucose; Chemical and Drug Induced Liver Injury; Cytosol; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Fat Emulsions, Intravenous; Galactosamine; Hepatectomy; Liver Diseases; Liver Regeneration; Male; Mononuclear Phagocyte System; Rats; Rats, Inbred Strains	1985
D-galactosamine-induced liver injury: a rat model to study the heterogeneity of the oligosaccharide chains of alpha 1-acid glycoprotein. Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 1985, Volume: 23, Issue:4 Topics: Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Galactosamine; Immunoelectrophoresis, Two-Dimensional; Male; Oligosaccharides; Orosomucoid; Rats; Rats, Inbred Strains; Sialic Acids; Time Factors	1985
[Liver tissue enzymes in rats with galactosamine hepatitis during simultaneous administration of choline-orotate]. Ceskoslovenska gynekologie, 1973, Volume: 27, Issue:5 Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Animals; Chemical and Drug Induced Liver Injury; Choline; Disease Models, Animal; Galactosamine; Hepatitis; Orotic Acid; Rats	1973
[Studies on the behavior of microsomal enzymes in the rat liver following galactosamine administration]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1971, Volume: 77 Topics: Aminopyrine N-Demethylase; Animals; Chemical and Drug Induced Liver Injury; Cytochromes; Disease Models, Animal; Galactosamine; Glucose-6-Phosphatase; Male; Microsomes, Liver; Rats	1971
[Therapeutic attempt in experimental hepatitis]. Acta medica Iugoslavica, 1974, Volume: 28, Issue:5 Topics: Animals; Disease Models, Animal; Female; Galactosamine; Hepatitis A; Male; Myocardium; Rats; Tissue Extracts	1974
Influence of liver-RES on toxic liver damage due to galactosamine. Acta hepato-gastroenterologica, 1974, Volume: 21, Issue:1 Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Coagulation Factors; Blood Platelets; Blood Proteins; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models, Animal; Fibrinogen; Galactosamine; Hemolysis; Male; Mononuclear Phagocyte System; Phagocytosis; Rats	1974
Influence of D-galactosamine hydrochloride on microsomal phospholipid, protein- and cytochrome P-450-content in guinea pig liver. Acta hepato-gastroenterologica, 1974, Volume: 21, Issue:2 Topics: Animals; Aspartate Aminotransferases; Bilirubin; Carbon Radioisotopes; Cytochrome P-450 Enzyme System; Disease Models, Animal; Galactosamine; Guinea Pigs; Hepatitis; Liver Function Tests; Male; Microsomes, Liver; Organ Size; Phospholipids; Proteins	1974
[Antihepatotoxic influence of silymarin on galactosamine hepatitis in the rat]. Klinische Wochenschrift, 1972, Nov-15, Volume: 50, Issue:22 Topics: Alanine Transaminase; Alcohols; Animals; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Flavonoids; Galactosamine; L-Lactate Dehydrogenase; Liver; Prothrombin Time; Rats; Succinate Dehydrogenase	1972
[The effect of D-penicillamine on the galactosamine hepatitis model in the rat]. Arzneimittel-Forschung, 1973, Volume: 23, Issue:1 Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Lipids; Liver; Penicillamine; Rats; Uracil Nucleotides	1973
Experimental hepatitis induced by D-galactosamine. Experimental and molecular pathology, 1968, Volume: 9, Issue:2 Topics: Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Glucose; Guinea Pigs; Liver; Liver Glycogen; Male; Mice; Mice, Inbred Strains; Rabbits; Rats; Rats, Inbred Strains	1968
["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis]. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1972, Volume: 353, Issue:5 Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Regeneration; Rats; Uracil Nucleotides	1972
[Electron optic studies on galactosamine-induced lesions in the rat liver]. Klinische Wochenschrift, 1971, Nov-15, Volume: 49, Issue:22 Topics: Animals; Chemical and Drug Induced Liver Injury; Cytoplasm; Disease Models, Animal; Female; Galactosamine; Hexosamines; Liver Diseases; Microscopy, Electron; Mitochondria, Liver; Rats	1971
[Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1971, Volume: 77 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Membrane; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Nucleotidases; Oxidoreductases; Rats	1971